======================================================================
HIERARCHICAL REGRESSION ANALYSIS SUMMARY
======================================================================

Model Structure:
  Model 0: age + gender
  Model 1: Model 0 + DASS-21 (depression, anxiety, stress)
  Model 2: Model 1 + UCLA loneliness
  Model 3: Model 2 + UCLA x Gender interaction

----------------------------------------------------------------------

Outcome: PRP Delay Effect (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0065, p = 0.704
  Step 2 (UCLA):        Delta R^2 = 0.0073, p = 0.218 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0126, p = 0.134 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 18.1959, SE = 14.7344, t = 1.23, p = 0.217

UCLA x Gender Interaction (Model 3):
  beta = 35.7371, SE = 23.7235, p = 0.132

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 14.4299, p = 0.428
  Male (n=79):   beta = 12.4695, p = 0.602

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.804
  Shapiro-Wilk p: 0.324


Outcome: PRP T2 Mean RT (Short SOA) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0178, p = 0.274
  Step 2 (UCLA):        Delta R^2 = 0.0028, p = 0.459 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0144, p = 0.144 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 18.9169, SE = 25.5122, t = 0.74, p = 0.458

UCLA x Gender Interaction (Model 3):
  beta = 63.5388, SE = 43.2997, p = 0.142

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 14.7070, p = 0.636
  Male (n=79):   beta = 3.8777, p = 0.929

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.734
  Shapiro-Wilk p: 0.004


Outcome: PRP T2 Mean RT (Long SOA) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0295, p = 0.109
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.968 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0057, p = 0.381 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.7210, SE = 17.7192, t = 0.04, p = 0.968

UCLA x Gender Interaction (Model 3):
  beta = 27.8017, SE = 31.6299, p = 0.379

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.2771, p = 0.990
  Male (n=79):   beta = -8.5917, p = 0.778

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.753
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 RT SD (Short SOA) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0008, p = 0.983
  Step 2 (UCLA):        Delta R^2 = 0.0031, p = 0.434 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0045, p = 0.382 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 7.4842, SE = 9.5392, t = 0.78, p = 0.433

UCLA x Gender Interaction (Model 3):
  beta = 13.5692, SE = 15.4931, p = 0.381

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 5.7243, p = 0.654
  Male (n=79):   beta = 5.6279, p = 0.681

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.784
  Shapiro-Wilk p: 0.176


Outcome: PRP T2 RT SD (Long SOA) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0073, p = 0.687
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.979 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0025, p = 0.478 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.2967, SE = 11.3126, t = -0.03, p = 0.979

UCLA x Gender Interaction (Model 3):
  beta = 12.4140, SE = 17.4713, p = 0.477

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.5500, p = 0.971
  Male (n=79):   beta = -5.7733, p = 0.729

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.797
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Coefficient of Variation (All) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0315, p = 0.099
  Step 2 (UCLA):        Delta R^2 = 0.0010, p = 0.680 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.970 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0026, SE = 0.0062, t = 0.41, p = 0.679

UCLA x Gender Interaction (Model 3):
  beta = -0.0003, SE = 0.0094, p = 0.970

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0015, p = 0.851
  Male (n=79):   beta = 0.0108, p = 0.356

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.755
  Shapiro-Wilk p: 0.151


Outcome: PRP T2 CV (Short SOA) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0143, p = 0.416
  Step 2 (UCLA):        Delta R^2 = 0.0003, p = 0.826 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0016, p = 0.590 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0016, SE = 0.0072, t = 0.22, p = 0.825

UCLA x Gender Interaction (Model 3):
  beta = -0.0056, SE = 0.0103, p = 0.589

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0004, p = 0.962
  Male (n=79):   beta = 0.0055, p = 0.672

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.504
  Shapiro-Wilk p: 0.051


Outcome: PRP T2 CV (Long SOA) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0044, p = 0.835
  Step 2 (UCLA):        Delta R^2 = 0.0010, p = 0.648 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0035, p = 0.434 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0051, SE = 0.0111, t = -0.46, p = 0.647

UCLA x Gender Interaction (Model 3):
  beta = 0.0140, SE = 0.0179, p = 0.433

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0078, p = 0.597
  Male (n=79):   beta = -0.0027, p = 0.869

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.879
  Shapiro-Wilk p: < 0.001


Outcome: PRP Error Cascade Rate (N = 143)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0104, p = 0.695
  Step 2 (UCLA):        Delta R^2 = 0.0110, p = 0.176 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0134, p = 0.107 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0183, SE = 0.0134, t = 1.36, p = 0.174

UCLA x Gender Interaction (Model 3):
  beta = 0.0301, SE = 0.0186, p = 0.104

Gender-Stratified UCLA Effects:
  Female (n=96): beta = 0.0084, p = 0.594
  Male (n=47):   beta = 0.0368, p = 0.190

Diagnostics:
  VIF max: 2.91
  Breusch-Pagan p: 0.853
  Shapiro-Wilk p: < 0.001


Outcome: PRP Cascade Inflation (N = 129)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0044, p = 0.907
  Step 2 (UCLA):        Delta R^2 = 0.0008, p = 0.628 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0148, p = 0.044 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.1921, SE = 0.3959, t = 0.49, p = 0.627

UCLA x Gender Interaction (Model 3):
  beta = 1.2155, SE = 0.5980, p = 0.042

Gender-Stratified UCLA Effects:
  Female (n=87): beta = -0.1380, p = 0.805
  Male (n=42):   beta = 0.7747, p = 0.240

Diagnostics:
  VIF max: 2.96
  Breusch-Pagan p: 0.947
  Shapiro-Wilk p: < 0.001


Outcome: PRP Post-Error Slowing (ms) (N = 166)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0103, p = 0.630
  Step 2 (UCLA):        Delta R^2 = 0.0024, p = 0.480 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0044, p = 0.384 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 26.9622, SE = 38.0838, t = 0.71, p = 0.479

UCLA x Gender Interaction (Model 3):
  beta = 51.7994, SE = 59.3859, p = 0.383

Gender-Stratified UCLA Effects:
  Female (n=102): beta = 27.6795, p = 0.577
  Male (n=64):   beta = -11.9158, p = 0.821

Diagnostics:
  VIF max: 2.80
  Breusch-Pagan p: 0.944
  Shapiro-Wilk p: < 0.001


Outcome: PRP Valid T2 Trial Count (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0173, p = 0.320
  Step 2 (UCLA):        Delta R^2 = 0.0027, p = 0.507 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0077, p = 0.218 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.4863, SE = 0.7323, t = -0.66, p = 0.507

UCLA x Gender Interaction (Model 3):
  beta = -1.2207, SE = 0.9884, p = 0.217

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0998, p = 0.920
  Male (n=79):   beta = -0.8789, p = 0.463

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.235
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian mu (Short SOA) (N = 200)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0218, p = 0.205
  Step 2 (UCLA):        Delta R^2 = 0.0061, p = 0.322 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0104, p = 0.274 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 31.0668, SE = 31.2589, t = 0.99, p = 0.320

UCLA x Gender Interaction (Model 3):
  beta = 60.5923, SE = 55.2266, p = 0.273

Gender-Stratified UCLA Effects:
  Female (n=121): beta = 25.4310, p = 0.512
  Male (n=79):   beta = 17.7883, p = 0.747

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.571
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (Short SOA) (N = 200)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0196, p = 0.260
  Step 2 (UCLA):        Delta R^2 = 0.0182, p = 0.085 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0128, p = 0.171 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 20.3507, SE = 11.7436, t = 1.73, p = 0.083

UCLA x Gender Interaction (Model 3):
  beta = 25.4918, SE = 18.5698, p = 0.170

Gender-Stratified UCLA Effects:
  Female (n=121): beta = 13.0510, p = 0.400
  Male (n=79):   beta = 24.5220, p = 0.149

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.583
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (Short SOA) (N = 200)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0159, p = 0.370
  Step 2 (UCLA):        Delta R^2 = 0.0028, p = 0.480 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.974 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -11.7309, SE = 16.5907, t = -0.71, p = 0.480

UCLA x Gender Interaction (Model 3):
  beta = 0.8513, SE = 26.3614, p = 0.974

Gender-Stratified UCLA Effects:
  Female (n=121): beta = -9.9986, p = 0.648
  Male (n=79):   beta = -13.9156, p = 0.605

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.425
  Shapiro-Wilk p: 0.212


Outcome: PRP Ex-Gaussian mu (Long SOA) (N = 195)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0356, p = 0.074
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.924 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0048, p = 0.401 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 1.2248, SE = 12.7386, t = 0.10, p = 0.923

UCLA x Gender Interaction (Model 3):
  beta = 18.7230, SE = 22.2458, p = 0.400

Gender-Stratified UCLA Effects:
  Female (n=116): beta = -2.0150, p = 0.904
  Male (n=79):   beta = 0.2235, p = 0.991

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.752
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (Long SOA) (N = 195)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0371, p = 0.066
  Step 2 (UCLA):        Delta R^2 = 0.0013, p = 0.582 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0010, p = 0.643 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 3.0394, SE = 5.5126, t = 0.55, p = 0.581

UCLA x Gender Interaction (Model 3):
  beta = 4.0372, SE = 8.6950, p = 0.642

Gender-Stratified UCLA Effects:
  Female (n=116): beta = -1.2592, p = 0.865
  Male (n=79):   beta = 8.8504, p = 0.322

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.813
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (Long SOA) (N = 195)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0192, p = 0.288
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.874 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0019, p = 0.566 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -2.0495, SE = 12.9332, t = -0.16, p = 0.874

UCLA x Gender Interaction (Model 3):
  beta = 11.7576, SE = 20.4575, p = 0.565

Gender-Stratified UCLA Effects:
  Female (n=116): beta = -1.7355, p = 0.919
  Male (n=79):   beta = -8.9051, p = 0.666

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.696
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian mu (Overall) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0339, p = 0.068
  Step 2 (UCLA):        Delta R^2 = 0.0002, p = 0.853 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0025, p = 0.580 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -5.2205, SE = 28.1248, t = -0.19, p = 0.853

UCLA x Gender Interaction (Model 3):
  beta = 27.0058, SE = 48.7648, p = 0.580

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 1.4301, p = 0.965
  Male (n=79):   beta = -28.6934, p = 0.628

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.441
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (Overall) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0216, p = 0.207
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.995 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0018, p = 0.634 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0845, SE = 14.5358, t = -0.01, p = 0.995

UCLA x Gender Interaction (Model 3):
  beta = 11.9665, SE = 25.0782, p = 0.633

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 1.9414, p = 0.913
  Male (n=79):   beta = -9.6446, p = 0.734

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.281
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (Overall) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0143, p = 0.420
  Step 2 (UCLA):        Delta R^2 = 0.0041, p = 0.376 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0050, p = 0.378 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 12.7642, SE = 14.3997, t = 0.89, p = 0.375

UCLA x Gender Interaction (Model 3):
  beta = 21.0075, SE = 23.7524, p = 0.376

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 4.6937, p = 0.784
  Male (n=79):   beta = 21.4767, p = 0.457

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.780
  Shapiro-Wilk p: 0.246


Outcome: PRP Ex-Gaussian mu (Bottleneck) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0305, p = 0.097
  Step 2 (UCLA):        Delta R^2 = 0.0053, p = 0.344 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0103, p = 0.265 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 24.3898, SE = 25.6997, t = 0.95, p = 0.343

UCLA x Gender Interaction (Model 3):
  beta = 51.4738, SE = 46.0361, p = 0.264

Gender-Stratified UCLA Effects:
  Female (n=115): beta = 14.4247, p = 0.641
  Male (n=79):   beta = 17.5648, p = 0.703

Diagnostics:
  VIF max: 2.58
  Breusch-Pagan p: 0.445
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (Bottleneck) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0494, p = 0.020
  Step 2 (UCLA):        Delta R^2 = 0.0129, p = 0.113 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0086, p = 0.250 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 17.7526, SE = 11.1499, t = 1.59, p = 0.111

UCLA x Gender Interaction (Model 3):
  beta = 21.7462, SE = 18.8259, p = 0.248

Gender-Stratified UCLA Effects:
  Female (n=115): beta = 13.5445, p = 0.349
  Male (n=79):   beta = 15.6716, p = 0.407

Diagnostics:
  VIF max: 2.58
  Breusch-Pagan p: 0.884
  Shapiro-Wilk p: 0.005


Outcome: PRP Ex-Gaussian tau (Bottleneck) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0375, p = 0.063
  Step 2 (UCLA):        Delta R^2 = 0.0005, p = 0.765 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0018, p = 0.633 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -5.6639, SE = 18.9380, t = -0.30, p = 0.765

UCLA x Gender Interaction (Model 3):
  beta = -15.5473, SE = 32.5075, p = 0.632

Gender-Stratified UCLA Effects:
  Female (n=115): beta = -1.3433, p = 0.952
  Male (n=79):   beta = -5.0105, p = 0.892

Diagnostics:
  VIF max: 2.58
  Breusch-Pagan p: 0.545
  Shapiro-Wilk p: 0.015


Outcome: PRP CB Base RT (ms) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0259, p = 0.153
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.948 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0031, p = 0.509 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -1.1602, SE = 17.9134, t = -0.06, p = 0.948

UCLA x Gender Interaction (Model 3):
  beta = 21.2166, SE = 32.0504, p = 0.508

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 1.5026, p = 0.948
  Male (n=79):   beta = -15.0861, p = 0.622

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.796
  Shapiro-Wilk p: < 0.001


Outcome: PRP CB Bottleneck Duration (ms) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0031, p = 0.882
  Step 2 (UCLA):        Delta R^2 = 0.0039, p = 0.407 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0152, p = 0.108 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 14.5667, SE = 17.5123, t = 0.83, p = 0.406

UCLA x Gender Interaction (Model 3):
  beta = 43.0237, SE = 26.6793, p = 0.107

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 7.1185, p = 0.748
  Male (n=79):   beta = 16.5765, p = 0.562

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.682
  Shapiro-Wilk p: 0.178


Outcome: PRP CB Model R-squared (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0083, p = 0.645
  Step 2 (UCLA):        Delta R^2 = 0.0182, p = 0.065 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0041, p = 0.429 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0278, SE = 0.0149, t = 1.86, p = 0.063

UCLA x Gender Interaction (Model 3):
  beta = 0.0197, SE = 0.0248, p = 0.428

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0232, p = 0.218
  Male (n=79):   beta = 0.0311, p = 0.222

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.390
  Shapiro-Wilk p: < 0.001


Outcome: PRP CB Slope (short SOA) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0207, p = 0.251
  Step 2 (UCLA):        Delta R^2 = 0.0150, p = 0.080 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0034, p = 0.409 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0830, SE = 0.0472, t = -1.76, p = 0.078

UCLA x Gender Interaction (Model 3):
  beta = -0.0587, SE = 0.0709, p = 0.408

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0763, p = 0.165
  Male (n=79):   beta = -0.0731, p = 0.413

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.630
  Shapiro-Wilk p: 0.109


Outcome: PRP Slow-State Probability (Baseline) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0222, p = 0.219
  Step 2 (UCLA):        Delta R^2 = 0.0095, p = 0.183 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0002, p = 0.843 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0287, SE = 0.0215, t = 1.34, p = 0.181

UCLA x Gender Interaction (Model 3):
  beta = 0.0065, SE = 0.0327, p = 0.843

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0332, p = 0.231
  Male (n=79):   beta = 0.0188, p = 0.608

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.200
  Shapiro-Wilk p: < 0.001


Outcome: PRP Slow-State Prob (Post-Error) (N = 179)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0073, p = 0.731
  Step 2 (UCLA):        Delta R^2 = 0.0002, p = 0.861 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0025, p = 0.515 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0056, SE = 0.0322, t = 0.18, p = 0.861

UCLA x Gender Interaction (Model 3):
  beta = 0.0306, SE = 0.0469, p = 0.514

Gender-Stratified UCLA Effects:
  Female (n=111): beta = 0.0031, p = 0.936
  Male (n=68):   beta = 0.0028, p = 0.958

Diagnostics:
  VIF max: 2.78
  Breusch-Pagan p: 0.808
  Shapiro-Wilk p: < 0.001


Outcome: PRP Slow-State Prob Delta (Post-Error) (N = 179)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0074, p = 0.730
  Step 2 (UCLA):        Delta R^2 = 0.0050, p = 0.290 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0004, p = 0.772 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0216, SE = 0.0203, t = -1.06, p = 0.288

UCLA x Gender Interaction (Model 3):
  beta = 0.0094, SE = 0.0324, p = 0.772

Gender-Stratified UCLA Effects:
  Female (n=111): beta = -0.0229, p = 0.364
  Male (n=68):   beta = -0.0268, p = 0.450

Diagnostics:
  VIF max: 2.78
  Breusch-Pagan p: 0.593
  Shapiro-Wilk p: 0.884


Outcome: PRP Slow-State Prob (Stable) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0202, p = 0.261
  Step 2 (UCLA):        Delta R^2 = 0.0078, p = 0.223 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.960 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0267, SE = 0.0219, t = 1.22, p = 0.222

UCLA x Gender Interaction (Model 3):
  beta = 0.0017, SE = 0.0337, p = 0.960

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0328, p = 0.246
  Male (n=79):   beta = 0.0149, p = 0.686

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.160
  Shapiro-Wilk p: < 0.001


Outcome: PRP Slow-State Prob Delta (Stable) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0066, p = 0.730
  Step 2 (UCLA):        Delta R^2 = 0.0024, p = 0.518 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0060, p = 0.211 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0020, SE = 0.0032, t = -0.65, p = 0.518

UCLA x Gender Interaction (Model 3):
  beta = -0.0048, SE = 0.0038, p = 0.209

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0004, p = 0.934
  Male (n=79):   beta = -0.0039, p = 0.342

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.665
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Cost (Short - Long) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0025, p = 0.918
  Step 2 (UCLA):        Delta R^2 = 0.0213, p = 0.023 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.991 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 46.2266, SE = 20.1146, t = 2.30, p = 0.022

UCLA x Gender Interaction (Model 3):
  beta = 0.3800, SE = 33.1155, p = 0.991

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 33.1631, p = 0.217
  Male (n=79):   beta = 69.7159, p = 0.035

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.744
  Shapiro-Wilk p: < 0.001


Outcome: PRP RT1-RT2 Coupling (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0008, p = 0.982
  Step 2 (UCLA):        Delta R^2 = 0.0068, p = 0.169 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0003, p = 0.792 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0175, SE = 0.0127, t = 1.38, p = 0.167

UCLA x Gender Interaction (Model 3):
  beta = 0.0057, SE = 0.0217, p = 0.792

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0100, p = 0.515
  Male (n=79):   beta = 0.0305, p = 0.203

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.761
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 RT (T1 Error) (N = 143)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0534, p = 0.044
  Step 2 (UCLA):        Delta R^2 = 0.0039, p = 0.499 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0127, p = 0.157 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 47.7430, SE = 70.4216, t = 0.68, p = 0.498

UCLA x Gender Interaction (Model 3):
  beta = 129.3739, SE = 90.9260, p = 0.155

Gender-Stratified UCLA Effects:
  Female (n=96): beta = 35.1691, p = 0.709
  Male (n=47):   beta = 65.0649, p = 0.635

Diagnostics:
  VIF max: 2.91
  Breusch-Pagan p: 0.526
  Shapiro-Wilk p: 0.898


Outcome: PRP T2 RT (T1 Correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0238, p = 0.164
  Step 2 (UCLA):        Delta R^2 = 0.0005, p = 0.771 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0102, p = 0.221 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 6.7039, SE = 22.9532, t = 0.29, p = 0.770

UCLA x Gender Interaction (Model 3):
  beta = 47.6342, SE = 38.7750, p = 0.219

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 5.6072, p = 0.844
  Male (n=79):   beta = -8.4802, p = 0.832

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.874
  Shapiro-Wilk p: 0.002


Outcome: PRP T2 Interference (T1 Error - Correct) (N = 143)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0321, p = 0.200
  Step 2 (UCLA):        Delta R^2 = 0.0044, p = 0.526 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0036, p = 0.534 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 45.3081, SE = 71.1999, t = 0.64, p = 0.525

UCLA x Gender Interaction (Model 3):
  beta = 61.4633, SE = 98.4899, p = 0.533

Gender-Stratified UCLA Effects:
  Female (n=96): beta = 26.6625, p = 0.788
  Male (n=47):   beta = 107.9623, p = 0.444

Diagnostics:
  VIF max: 2.91
  Breusch-Pagan p: 0.638
  Shapiro-Wilk p: 0.500


Outcome: PRP T2 RT Slope (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0302, p = 0.110
  Step 2 (UCLA):        Delta R^2 = 0.0026, p = 0.460 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0134, p = 0.110 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.1686, SE = 0.2279, t = 0.74, p = 0.460

UCLA x Gender Interaction (Model 3):
  beta = -0.5745, SE = 0.3578, p = 0.108

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.3595, p = 0.243
  Male (n=79):   beta = -0.0381, p = 0.914

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.576
  Shapiro-Wilk p: 0.272


Outcome: PRP Order Violation Rate (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0060, p = 0.754
  Step 2 (UCLA):        Delta R^2 = 0.0022, p = 0.579 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0014, p = 0.650 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0020, SE = 0.0037, t = 0.56, p = 0.578

UCLA x Gender Interaction (Model 3):
  beta = 0.0024, SE = 0.0053, p = 0.649

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0001, p = 0.982
  Male (n=79):   beta = 0.0053, p = 0.340

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.695
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1-only Rate (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0099, p = 0.575
  Step 2 (UCLA):        Delta R^2 = 0.0031, p = 0.488 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0039, p = 0.195 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0006, SE = 0.0008, t = 0.69, p = 0.487

UCLA x Gender Interaction (Model 3):
  beta = 0.0010, SE = 0.0007, p = 0.193

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0005, p = 0.679
  Male (n=79):   beta = 0.0003, p = 0.640

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.316
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2-only Rate (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0126, p = 0.475
  Step 2 (UCLA):        Delta R^2 = 0.0004, p = 0.718 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0003, p = 0.748 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0002, SE = 0.0007, t = -0.36, p = 0.718

UCLA x Gender Interaction (Model 3):
  beta = 0.0004, SE = 0.0011, p = 0.748

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0000, p = 0.997
  Male (n=79):   beta = -0.0008, p = 0.422

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.766
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 While T1 Pending Rate (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0073, p = 0.694
  Step 2 (UCLA):        Delta R^2 = 0.0016, p = 0.632 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0014, p = 0.645 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0018, SE = 0.0038, t = 0.48, p = 0.632

UCLA x Gender Interaction (Model 3):
  beta = 0.0025, SE = 0.0054, p = 0.645

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0000, p = 0.994
  Male (n=79):   beta = 0.0048, p = 0.431

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.641
  Shapiro-Wilk p: < 0.001


Outcome: PRP IRI Mean (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0059, p = 0.753
  Step 2 (UCLA):        Delta R^2 = 0.0077, p = 0.210 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0044, p = 0.373 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 19.7008, SE = 15.6579, t = 1.26, p = 0.208

UCLA x Gender Interaction (Model 3):
  beta = -22.3628, SE = 25.0200, p = 0.371

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 21.1429, p = 0.334
  Male (n=79):   beta = 21.4483, p = 0.410

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.403
  Shapiro-Wilk p: 0.007


Outcome: PRP IRI Median (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0072, p = 0.688
  Step 2 (UCLA):        Delta R^2 = 0.0081, p = 0.229 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0029, p = 0.454 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 20.8803, SE = 17.3211, t = 1.21, p = 0.228

UCLA x Gender Interaction (Model 3):
  beta = -18.5168, SE = 24.6541, p = 0.453

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 25.3762, p = 0.283
  Male (n=79):   beta = 14.9982, p = 0.603

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.256
  Shapiro-Wilk p: 0.072


Outcome: PRP IRI p10 (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0152, p = 0.359
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 1.000 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.914 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0006, SE = 11.2811, t = -0.00, p = 1.000

UCLA x Gender Interaction (Model 3):
  beta = 1.8369, SE = 16.8905, p = 0.913

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0755, p = 0.996
  Male (n=79):   beta = -1.7557, p = 0.920

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.029
  Shapiro-Wilk p: 0.018


Outcome: PRP IRI p25 (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0126, p = 0.454
  Step 2 (UCLA):        Delta R^2 = 0.0009, p = 0.686 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0002, p = 0.826 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 5.5760, SE = 13.7762, t = 0.40, p = 0.686

UCLA x Gender Interaction (Model 3):
  beta = -4.4748, SE = 20.3801, p = 0.826

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 6.5188, p = 0.732
  Male (n=79):   beta = 3.5635, p = 0.874

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.042
  Shapiro-Wilk p: 0.047


Outcome: PRP T1 Error Run Mean (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0219, p = 0.203
  Step 2 (UCLA):        Delta R^2 = 0.0009, p = 0.657 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.951 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0230, SE = 0.0516, t = 0.45, p = 0.656

UCLA x Gender Interaction (Model 3):
  beta = -0.0053, SE = 0.0866, p = 0.951

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0299, p = 0.659
  Male (n=79):   beta = -0.0023, p = 0.980

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.405
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Error Run Max (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0179, p = 0.290
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.893 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0012, p = 0.647 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0103, SE = 0.0763, t = 0.13, p = 0.893

UCLA x Gender Interaction (Model 3):
  beta = 0.0525, SE = 0.1144, p = 0.646

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0015, p = 0.989
  Male (n=79):   beta = 0.0031, p = 0.977

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.676
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Error Run Mean (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0506, p = 0.017
  Step 2 (UCLA):        Delta R^2 = 0.0024, p = 0.549 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.993 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0291, SE = 0.0484, t = -0.60, p = 0.548

UCLA x Gender Interaction (Model 3):
  beta = -0.0005, SE = 0.0630, p = 0.993

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0092, p = 0.884
  Male (n=79):   beta = -0.0736, p = 0.382

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.389
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Error Run Max (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0322, p = 0.094
  Step 2 (UCLA):        Delta R^2 = 0.0064, p = 0.334 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0008, p = 0.703 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0708, SE = 0.0731, t = -0.97, p = 0.333

UCLA x Gender Interaction (Model 3):
  beta = 0.0367, SE = 0.0960, p = 0.703

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0645, p = 0.499
  Male (n=79):   beta = -0.0950, p = 0.424

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.728
  Shapiro-Wilk p: < 0.001


Outcome: PRP Cascade Run Mean (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0083, p = 0.649
  Step 2 (UCLA):        Delta R^2 = 0.0068, p = 0.288 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0240, p = 0.046 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0395, SE = 0.0371, t = 1.07, p = 0.287

UCLA x Gender Interaction (Model 3):
  beta = 0.1112, SE = 0.0554, p = 0.045

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0068, p = 0.888
  Male (n=79):   beta = 0.0762, p = 0.241

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.177
  Shapiro-Wilk p: < 0.001


Outcome: PRP Cascade Run Max (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0083, p = 0.649
  Step 2 (UCLA):        Delta R^2 = 0.0068, p = 0.288 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0240, p = 0.046 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0395, SE = 0.0371, t = 1.07, p = 0.287

UCLA x Gender Interaction (Model 3):
  beta = 0.1112, SE = 0.0554, p = 0.045

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0068, p = 0.888
  Male (n=79):   beta = 0.0762, p = 0.241

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.177
  Shapiro-Wilk p: < 0.001


Outcome: PRP DFA Alpha (Short SOA, correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0129, p = 0.462
  Step 2 (UCLA):        Delta R^2 = 0.0006, p = 0.741 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0014, p = 0.657 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0072, SE = 0.0217, t = 0.33, p = 0.740

UCLA x Gender Interaction (Model 3):
  beta = -0.0161, SE = 0.0361, p = 0.657

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0116, p = 0.691
  Male (n=79):   beta = -0.0039, p = 0.911

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.338
  Shapiro-Wilk p: 0.004


Outcome: PRP DFA Alpha (Long SOA, correct) (N = 192)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0280, p = 0.148
  Step 2 (UCLA):        Delta R^2 = 0.0038, p = 0.384 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0035, p = 0.377 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0993, SE = 0.1138, t = -0.87, p = 0.383

UCLA x Gender Interaction (Model 3):
  beta = 0.1437, SE = 0.1622, p = 0.376

Gender-Stratified UCLA Effects:
  Female (n=113): beta = -0.1093, p = 0.484
  Male (n=79):   beta = -0.0896, p = 0.596

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.307
  Shapiro-Wilk p: < 0.001


Outcome: PRP Lag-1 Autocorr (Short SOA, correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0053, p = 0.790
  Step 2 (UCLA):        Delta R^2 = 0.0061, p = 0.329 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0048, p = 0.427 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0181, SE = 0.0185, t = -0.98, p = 0.328

UCLA x Gender Interaction (Model 3):
  beta = -0.0240, SE = 0.0301, p = 0.426

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0113, p = 0.664
  Male (n=79):   beta = -0.0275, p = 0.288

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.342
  Shapiro-Wilk p: 0.469


Outcome: PRP Lag-1 Autocorr (Long SOA, correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0021, p = 0.937
  Step 2 (UCLA):        Delta R^2 = 0.0026, p = 0.508 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0051, p = 0.357 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0152, SE = 0.0230, t = 0.66, p = 0.508

UCLA x Gender Interaction (Model 3):
  beta = -0.0322, SE = 0.0349, p = 0.356

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0455, p = 0.099
  Male (n=79):   beta = -0.0403, p = 0.286

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.467
  Shapiro-Wilk p: 0.010


Outcome: PRP Slow Run Mean (Short SOA, correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0103, p = 0.562
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.943 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0019, p = 0.548 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0030, SE = 0.0424, t = -0.07, p = 0.943

UCLA x Gender Interaction (Model 3):
  beta = -0.0373, SE = 0.0619, p = 0.547

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0138, p = 0.813
  Male (n=79):   beta = -0.0460, p = 0.510

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.517
  Shapiro-Wilk p: < 0.001


Outcome: PRP Slow Run Max (Short SOA, correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0056, p = 0.776
  Step 2 (UCLA):        Delta R^2 = 0.0045, p = 0.349 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0039, p = 0.437 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.1744, SE = 0.1856, t = 0.94, p = 0.347

UCLA x Gender Interaction (Model 3):
  beta = -0.2418, SE = 0.3106, p = 0.436

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.3510, p = 0.137
  Male (n=79):   beta = -0.1660, p = 0.601

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.571
  Shapiro-Wilk p: < 0.001


Outcome: PRP Fast Run Mean (Short SOA, correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0118, p = 0.504
  Step 2 (UCLA):        Delta R^2 = 0.0012, p = 0.651 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0005, p = 0.754 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0202, SE = 0.0447, t = 0.45, p = 0.651

UCLA x Gender Interaction (Model 3):
  beta = -0.0195, SE = 0.0623, p = 0.754

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0322, p = 0.605
  Male (n=79):   beta = -0.0169, p = 0.806

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.421
  Shapiro-Wilk p: < 0.001


Outcome: PRP Fast Run Max (Short SOA, correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0061, p = 0.753
  Step 2 (UCLA):        Delta R^2 = 0.0016, p = 0.630 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0004, p = 0.786 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0954, SE = 0.1976, t = -0.48, p = 0.629

UCLA x Gender Interaction (Model 3):
  beta = -0.0701, SE = 0.2580, p = 0.786

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0116, p = 0.965
  Male (n=79):   beta = -0.3728, p = 0.257

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.550
  Shapiro-Wilk p: < 0.001


Outcome: PRP Slow Run Mean (Long SOA, correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0165, p = 0.352
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.943 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0059, p = 0.246 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0041, SE = 0.0576, t = 0.07, p = 0.943

UCLA x Gender Interaction (Model 3):
  beta = 0.0918, SE = 0.0790, p = 0.245

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0311, p = 0.675
  Male (n=79):   beta = -0.0787, p = 0.505

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.331
  Shapiro-Wilk p: < 0.001


Outcome: PRP Slow Run Max (Long SOA, correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0194, p = 0.280
  Step 2 (UCLA):        Delta R^2 = 0.0011, p = 0.658 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0050, p = 0.323 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0677, SE = 0.1528, t = 0.44, p = 0.658

UCLA x Gender Interaction (Model 3):
  beta = 0.2171, SE = 0.2190, p = 0.321

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0802, p = 0.659
  Male (n=79):   beta = 0.0191, p = 0.951

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.235
  Shapiro-Wilk p: < 0.001


Outcome: PRP Fast Run Mean (Long SOA, correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0063, p = 0.743
  Step 2 (UCLA):        Delta R^2 = 0.0005, p = 0.693 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0062, p = 0.192 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0223, SE = 0.0564, t = 0.40, p = 0.692

UCLA x Gender Interaction (Model 3):
  beta = 0.1157, SE = 0.0884, p = 0.191

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0452, p = 0.518
  Male (n=79):   beta = -0.0581, p = 0.635

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.988
  Shapiro-Wilk p: < 0.001


Outcome: PRP Fast Run Max (Long SOA, correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0180, p = 0.306
  Step 2 (UCLA):        Delta R^2 = 0.0012, p = 0.627 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0032, p = 0.489 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0677, SE = 0.1389, t = 0.49, p = 0.626

UCLA x Gender Interaction (Model 3):
  beta = 0.1677, SE = 0.2420, p = 0.488

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.1560, p = 0.349
  Male (n=79):   beta = -0.1283, p = 0.633

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.290
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian mu (Bottleneck, correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0290, p = 0.113
  Step 2 (UCLA):        Delta R^2 = 0.0043, p = 0.394 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0077, p = 0.342 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 22.3290, SE = 26.1546, t = 0.85, p = 0.393

UCLA x Gender Interaction (Model 3):
  beta = 44.5668, SE = 46.8182, p = 0.341

Gender-Stratified UCLA Effects:
  Female (n=114): beta = 19.5660, p = 0.537
  Male (n=79):   beta = 6.6040, p = 0.890

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.523
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (Bottleneck, correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0461, p = 0.028
  Step 2 (UCLA):        Delta R^2 = 0.0069, p = 0.252 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0046, p = 0.402 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 13.3025, SE = 11.5870, t = 1.15, p = 0.251

UCLA x Gender Interaction (Model 3):
  beta = 16.2018, SE = 19.2748, p = 0.401

Gender-Stratified UCLA Effects:
  Female (n=114): beta = 13.4580, p = 0.384
  Male (n=79):   beta = 5.3294, p = 0.784

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.797
  Shapiro-Wilk p: 0.004


Outcome: PRP Ex-Gaussian tau (Bottleneck, correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0316, p = 0.107
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.929 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0007, p = 0.759 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 1.7256, SE = 19.4388, t = 0.09, p = 0.929

UCLA x Gender Interaction (Model 3):
  beta = -10.4228, SE = 33.8634, p = 0.758

Gender-Stratified UCLA Effects:
  Female (n=114): beta = 1.2428, p = 0.957
  Male (n=79):   beta = 7.5627, p = 0.846

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.847
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau Ratio (Short/Long) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0262, p = 0.163
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.981 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0006, p = 0.608 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0157, SE = 0.6510, t = -0.02, p = 0.981

UCLA x Gender Interaction (Model 3):
  beta = -0.4155, SE = 0.8084, p = 0.607

Gender-Stratified UCLA Effects:
  Female (n=115): beta = 0.6383, p = 0.321
  Male (n=79):   beta = -1.1243, p = 0.443

Diagnostics:
  VIF max: 2.58
  Breusch-Pagan p: 0.334
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau Ratio (Short/Long, correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0286, p = 0.133
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.841 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.830 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.1165, SE = 0.5785, t = -0.20, p = 0.840

UCLA x Gender Interaction (Model 3):
  beta = -0.1680, SE = 0.7817, p = 0.830

Gender-Stratified UCLA Effects:
  Female (n=114): beta = 0.3522, p = 0.444
  Male (n=79):   beta = -0.8806, p = 0.545

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.241
  Shapiro-Wilk p: < 0.001


Outcome: PRP Bottleneck AUC (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0246, p = 0.154
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.876 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0087, p = 0.249 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 3998.1325, SE = 25606.6331, t = 0.16, p = 0.876

UCLA x Gender Interaction (Model 3):
  beta = 49138.3201, SE = 42493.1202, p = 0.248

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 3407.6435, p = 0.915
  Male (n=79):   beta = -12420.9410, p = 0.782

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.948
  Shapiro-Wilk p: 0.001


Outcome: PRP Bottleneck Slope (Short Range) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0207, p = 0.251
  Step 2 (UCLA):        Delta R^2 = 0.0150, p = 0.080 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0034, p = 0.409 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0830, SE = 0.0472, t = -1.76, p = 0.078

UCLA x Gender Interaction (Model 3):
  beta = -0.0587, SE = 0.0709, p = 0.408

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0763, p = 0.165
  Male (n=79):   beta = -0.0731, p = 0.413

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.630
  Shapiro-Wilk p: 0.109


Outcome: PRP Bottleneck Slope (Long Range) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0087, p = 0.598
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.937 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0062, p = 0.311 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0015, SE = 0.0185, t = 0.08, p = 0.937

UCLA x Gender Interaction (Model 3):
  beta = -0.0289, SE = 0.0284, p = 0.310

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0033, p = 0.881
  Male (n=79):   beta = 0.0070, p = 0.842

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.979
  Shapiro-Wilk p: 0.189


Outcome: PRP RT2 Asymptote (Long SOA) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0290, p = 0.114
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.982 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0058, p = 0.376 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.3940, SE = 17.7109, t = 0.02, p = 0.982

UCLA x Gender Interaction (Model 3):
  beta = 28.0257, SE = 31.5910, p = 0.375

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.1068, p = 0.996
  Male (n=79):   beta = -8.6816, p = 0.777

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.767
  Shapiro-Wilk p: < 0.001


Outcome: PRP Bottleneck Curvature (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0378, p = 0.054
  Step 2 (UCLA):        Delta R^2 = 0.0082, p = 0.225 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0022, p = 0.542 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0000, SE = 0.0000, t = 1.22, p = 0.223

UCLA x Gender Interaction (Model 3):
  beta = 0.0000, SE = 0.0000, p = 0.541

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0000, p = 0.479
  Male (n=79):   beta = 0.0001, p = 0.412

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.469
  Shapiro-Wilk p: 0.001


Outcome: PRP CB AIC (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0079, p = 0.660
  Step 2 (UCLA):        Delta R^2 = 0.0072, p = 0.275 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.942 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.6987, SE = 0.6380, t = -1.10, p = 0.273

UCLA x Gender Interaction (Model 3):
  beta = 0.0598, SE = 0.8197, p = 0.942

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.5416, p = 0.513
  Male (n=79):   beta = -1.1580, p = 0.260

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.969
  Shapiro-Wilk p: < 0.001


Outcome: PRP CB BIC (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0079, p = 0.660
  Step 2 (UCLA):        Delta R^2 = 0.0072, p = 0.275 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.942 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.6987, SE = 0.6380, t = -1.10, p = 0.273

UCLA x Gender Interaction (Model 3):
  beta = 0.0598, SE = 0.8197, p = 0.942

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.5416, p = 0.513
  Male (n=79):   beta = -1.1580, p = 0.260

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.969
  Shapiro-Wilk p: < 0.001


Outcome: PRP CS Base RT (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0334, p = 0.076
  Step 2 (UCLA):        Delta R^2 = 0.0009, p = 0.696 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.937 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 8.3529, SE = 21.3666, t = 0.39, p = 0.696

UCLA x Gender Interaction (Model 3):
  beta = -2.9213, SE = 36.6842, p = 0.937

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 17.5588, p = 0.487
  Male (n=79):   beta = -9.1206, p = 0.821

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.243
  Shapiro-Wilk p: < 0.001


Outcome: PRP CS Amplitude (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0077, p = 0.635
  Step 2 (UCLA):        Delta R^2 = 0.0007, p = 0.733 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0142, p = 0.102 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 11.1029, SE = 32.4819, t = 0.34, p = 0.732

UCLA x Gender Interaction (Model 3):
  beta = 77.0399, SE = 46.8246, p = 0.100

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -7.7487, p = 0.837
  Male (n=79):   beta = 21.5172, p = 0.710

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.612
  Shapiro-Wilk p: 0.005


Outcome: PRP CS Tau (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0210, p = 0.228
  Step 2 (UCLA):        Delta R^2 = 0.0072, p = 0.242 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0015, p = 0.614 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -62.6539, SE = 53.3519, t = -1.17, p = 0.240

UCLA x Gender Interaction (Model 3):
  beta = 42.7825, SE = 84.7686, p = 0.614

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -77.6444, p = 0.266
  Male (n=79):   beta = -45.7181, p = 0.629

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.467
  Shapiro-Wilk p: < 0.001


Outcome: PRP CS R-squared (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0065, p = 0.734
  Step 2 (UCLA):        Delta R^2 = 0.0106, p = 0.190 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0021, p = 0.572 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0098, SE = 0.0074, t = 1.32, p = 0.188

UCLA x Gender Interaction (Model 3):
  beta = 0.0065, SE = 0.0114, p = 0.571

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0105, p = 0.088
  Male (n=79):   beta = 0.0066, p = 0.699

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.406
  Shapiro-Wilk p: < 0.001


Outcome: PRP CS RMSE (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0077, p = 0.677
  Step 2 (UCLA):        Delta R^2 = 0.0105, p = 0.159 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0002, p = 0.845 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -4.0384, SE = 2.8530, t = -1.42, p = 0.157

UCLA x Gender Interaction (Model 3):
  beta = 0.8499, SE = 4.3425, p = 0.845

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -4.9281, p = 0.112
  Male (n=79):   beta = -2.7600, p = 0.629

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.241
  Shapiro-Wilk p: < 0.001


Outcome: PRP CS AIC (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0062, p = 0.745
  Step 2 (UCLA):        Delta R^2 = 0.0150, p = 0.126 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0035, p = 0.402 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -1.0349, SE = 0.6737, t = -1.54, p = 0.124

UCLA x Gender Interaction (Model 3):
  beta = 0.7488, SE = 0.8906, p = 0.400

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -1.6172, p = 0.059
  Male (n=79):   beta = -0.1544, p = 0.889

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.179
  Shapiro-Wilk p: 0.019


Outcome: PRP CS BIC (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0062, p = 0.745
  Step 2 (UCLA):        Delta R^2 = 0.0150, p = 0.126 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0035, p = 0.402 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -1.0349, SE = 0.6737, t = -1.54, p = 0.124

UCLA x Gender Interaction (Model 3):
  beta = 0.7488, SE = 0.8906, p = 0.400

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -1.6172, p = 0.059
  Male (n=79):   beta = -0.1544, p = 0.889

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.179
  Shapiro-Wilk p: 0.019


Outcome: PRP Mix CB Weight (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0105, p = 0.550
  Step 2 (UCLA):        Delta R^2 = 0.0009, p = 0.685 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0035, p = 0.397 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0152, SE = 0.0374, t = 0.41, p = 0.684

UCLA x Gender Interaction (Model 3):
  beta = 0.0454, SE = 0.0536, p = 0.396

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0143, p = 0.775
  Male (n=79):   beta = 0.0683, p = 0.253

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.403
  Shapiro-Wilk p: < 0.001


Outcome: PRP Mix R-squared (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0063, p = 0.739
  Step 2 (UCLA):        Delta R^2 = 0.0122, p = 0.142 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0034, p = 0.461 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0103, SE = 0.0070, t = 1.47, p = 0.141

UCLA x Gender Interaction (Model 3):
  beta = 0.0082, SE = 0.0111, p = 0.461

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0094, p = 0.134
  Male (n=79):   beta = 0.0100, p = 0.526

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.269
  Shapiro-Wilk p: < 0.001


Outcome: PRP Mix RMSE (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0072, p = 0.698
  Step 2 (UCLA):        Delta R^2 = 0.0097, p = 0.181 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.972 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -3.9623, SE = 2.9541, t = -1.34, p = 0.180

UCLA x Gender Interaction (Model 3):
  beta = 0.1546, SE = 4.3962, p = 0.972

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -4.0667, p = 0.217
  Male (n=79):   beta = -4.2006, p = 0.469

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.230
  Shapiro-Wilk p: < 0.001


Outcome: PRP Mix AIC (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0066, p = 0.729
  Step 2 (UCLA):        Delta R^2 = 0.0113, p = 0.187 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0024, p = 0.486 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -1.0038, SE = 0.7588, t = -1.32, p = 0.186

UCLA x Gender Interaction (Model 3):
  beta = 0.6905, SE = 0.9885, p = 0.485

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -1.3732, p = 0.153
  Male (n=79):   beta = -0.6043, p = 0.632

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.240
  Shapiro-Wilk p: 0.021


Outcome: PRP Mix BIC (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0066, p = 0.729
  Step 2 (UCLA):        Delta R^2 = 0.0113, p = 0.187 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0024, p = 0.486 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -1.0038, SE = 0.7588, t = -1.32, p = 0.186

UCLA x Gender Interaction (Model 3):
  beta = 0.6905, SE = 0.9885, p = 0.485

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -1.3732, p = 0.153
  Male (n=79):   beta = -0.6043, p = 0.632

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.240
  Shapiro-Wilk p: 0.021


Outcome: PRP RT Fatigue Slope (Q4-Q1) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0310, p = 0.103
  Step 2 (UCLA):        Delta R^2 = 0.0009, p = 0.642 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0204, p = 0.057 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 9.2258, SE = 19.8133, t = 0.47, p = 0.641

UCLA x Gender Interaction (Model 3):
  beta = -64.8162, SE = 33.9131, p = 0.056

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 32.9232, p = 0.211
  Male (n=79):   beta = -21.1182, p = 0.507

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.380
  Shapiro-Wilk p: 0.021


Outcome: PRP CV Fatigue Slope (Q4-Q1) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0184, p = 0.291
  Step 2 (UCLA):        Delta R^2 = 0.0081, p = 0.185 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0451, p = 0.002 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0108, SE = 0.0081, t = -1.33, p = 0.184

UCLA x Gender Interaction (Model 3):
  beta = 0.0378, SE = 0.0121, p = 0.002

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0273, p = 0.004
  Male (n=79):   beta = 0.0124, p = 0.361

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.699
  Shapiro-Wilk p: 0.744


Outcome: PRP Accuracy Fatigue Slope (Q4-Q1) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0133, p = 0.455
  Step 2 (UCLA):        Delta R^2 = 0.0007, p = 0.740 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0013, p = 0.668 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0016, SE = 0.0048, t = -0.33, p = 0.740

UCLA x Gender Interaction (Model 3):
  beta = -0.0032, SE = 0.0074, p = 0.667

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0014, p = 0.808
  Male (n=79):   beta = -0.0082, p = 0.337

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.703
  Shapiro-Wilk p: < 0.001


Outcome: PRP Error Cascade Count (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0191, p = 0.287
  Step 2 (UCLA):        Delta R^2 = 0.0060, p = 0.296 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0036, p = 0.386 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0509, SE = 0.0486, t = -1.05, p = 0.295

UCLA x Gender Interaction (Model 3):
  beta = 0.0585, SE = 0.0673, p = 0.385

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0729, p = 0.252
  Male (n=79):   beta = -0.0192, p = 0.798

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.664
  Shapiro-Wilk p: < 0.001


Outcome: PRP Error Cascade Rate (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0193, p = 0.283
  Step 2 (UCLA):        Delta R^2 = 0.0059, p = 0.301 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0034, p = 0.397 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0428, SE = 0.0412, t = -1.04, p = 0.300

UCLA x Gender Interaction (Model 3):
  beta = 0.0483, SE = 0.0570, p = 0.396

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0614, p = 0.254
  Male (n=79):   beta = -0.0154, p = 0.811

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.661
  Shapiro-Wilk p: < 0.001


Outcome: PRP Error Cascade Mean Length (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0233, p = 0.200
  Step 2 (UCLA):        Delta R^2 = 0.0073, p = 0.279 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0009, p = 0.687 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0867, SE = 0.0798, t = -1.09, p = 0.277

UCLA x Gender Interaction (Model 3):
  beta = 0.0466, SE = 0.1154, p = 0.686

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.1081, p = 0.239
  Male (n=79):   beta = -0.0560, p = 0.706

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.692
  Shapiro-Wilk p: < 0.001


Outcome: PRP Error Cascade Max Length (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0236, p = 0.196
  Step 2 (UCLA):        Delta R^2 = 0.0097, p = 0.229 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0018, p = 0.578 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.1068, SE = 0.0884, t = -1.21, p = 0.227

UCLA x Gender Interaction (Model 3):
  beta = 0.0688, SE = 0.1233, p = 0.577

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.1396, p = 0.205
  Male (n=79):   beta = -0.0560, p = 0.706

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.609
  Shapiro-Wilk p: < 0.001


Outcome: PRP Error Cascade Trials (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0187, p = 0.295
  Step 2 (UCLA):        Delta R^2 = 0.0084, p = 0.252 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0041, p = 0.364 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.1350, SE = 0.1175, t = -1.15, p = 0.250

UCLA x Gender Interaction (Model 3):
  beta = 0.1406, SE = 0.1547, p = 0.363

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.1930, p = 0.240
  Male (n=79):   beta = -0.0447, p = 0.765

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.515
  Shapiro-Wilk p: < 0.001


Outcome: PRP Error Cascade Proportion (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0190, p = 0.289
  Step 2 (UCLA):        Delta R^2 = 0.0082, p = 0.255 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0039, p = 0.373 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.1132, SE = 0.0991, t = -1.14, p = 0.253

UCLA x Gender Interaction (Model 3):
  beta = 0.1164, SE = 0.1304, p = 0.372

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.1621, p = 0.240
  Male (n=79):   beta = -0.0360, p = 0.779

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.508
  Shapiro-Wilk p: < 0.001


Outcome: PRP Recovery RT Slope (N = 93)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0135, p = 0.748
  Step 2 (UCLA):        Delta R^2 = 0.0036, p = 0.573 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0293, p = 0.117 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -6.5211, SE = 11.5163, t = -0.57, p = 0.571

UCLA x Gender Interaction (Model 3):
  beta = 27.8811, SE = 17.5897, p = 0.113

Gender-Stratified UCLA Effects:
  Female (n=55): beta = -17.2764, p = 0.266
  Male (n=38):   beta = 18.1354, p = 0.187

Diagnostics:
  VIF max: 2.54
  Breusch-Pagan p: 0.681
  Shapiro-Wilk p: 0.212


Outcome: PRP Recovery Accuracy Slope (N = 93)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0152, p = 0.715
  Step 2 (UCLA):        Delta R^2 = 0.0386, p = 0.104 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0049, p = 0.575 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0082, SE = 0.0050, t = -1.64, p = 0.101

UCLA x Gender Interaction (Model 3):
  beta = 0.0043, SE = 0.0077, p = 0.574

Gender-Stratified UCLA Effects:
  Female (n=55): beta = -0.0103, p = 0.097
  Male (n=38):   beta = -0.0054, p = 0.575

Diagnostics:
  VIF max: 2.54
  Breusch-Pagan p: 0.566
  Shapiro-Wilk p: < 0.001


Outcome: PRP Momentum Slope (N = 53)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0566, p = 0.424
  Step 2 (UCLA):        Delta R^2 = 0.0009, p = 0.868 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0251, p = 0.477 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -2.3037, SE = 13.7684, t = -0.17, p = 0.867

UCLA x Gender Interaction (Model 3):
  beta = 20.8898, SE = 29.1209, p = 0.473

Gender-Stratified UCLA Effects:
  Female (n=32): beta = -16.8863, p = 0.387
  Male (n=21):   beta = 21.3056, p = 0.188

Diagnostics:
  VIF max: 1.99
  Breusch-Pagan p: 0.309
  Shapiro-Wilk p: 0.890


Outcome: PRP Momentum Mean Streak (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0070, p = 0.711
  Step 2 (UCLA):        Delta R^2 = 0.0084, p = 0.235 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0018, p = 0.532 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -2.1309, SE = 1.7901, t = -1.19, p = 0.234

UCLA x Gender Interaction (Model 3):
  beta = 1.4753, SE = 2.3584, p = 0.532

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -3.6717, p = 0.119
  Male (n=79):   beta = 0.4933, p = 0.873

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.094
  Shapiro-Wilk p: < 0.001


Outcome: PRP Momentum Max Streak (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0075, p = 0.686
  Step 2 (UCLA):        Delta R^2 = 0.0069, p = 0.268 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0032, p = 0.400 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -3.4065, SE = 3.0644, t = -1.11, p = 0.266

UCLA x Gender Interaction (Model 3):
  beta = 3.4906, SE = 4.1393, p = 0.399

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -6.0050, p = 0.135
  Male (n=79):   beta = 0.4791, p = 0.929

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.110
  Shapiro-Wilk p: < 0.001


Outcome: PRP Volatility RMSSD (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0071, p = 0.688
  Step 2 (UCLA):        Delta R^2 = 0.0021, p = 0.548 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0176, p = 0.083 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 7.5841, SE = 12.6124, t = 0.60, p = 0.548

UCLA x Gender Interaction (Model 3):
  beta = 33.0049, SE = 18.9264, p = 0.081

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -1.7672, p = 0.911
  Male (n=79):   beta = 14.8729, p = 0.479

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.224
  Shapiro-Wilk p: 0.257


Outcome: PRP Volatility (Detrended SD) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0028, p = 0.900
  Step 2 (UCLA):        Delta R^2 = 0.0024, p = 0.475 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0082, p = 0.222 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 5.8942, SE = 8.2268, t = 0.72, p = 0.474

UCLA x Gender Interaction (Model 3):
  beta = 16.4058, SE = 13.4009, p = 0.221

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 2.0716, p = 0.843
  Male (n=79):   beta = 6.8997, p = 0.605

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.443
  Shapiro-Wilk p: 0.120


Outcome: PRP IIV Intercept (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0387, p = 0.042
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.887 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0200, p = 0.073 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -3.7032, SE = 26.0395, t = -0.14, p = 0.887

UCLA x Gender Interaction (Model 3):
  beta = 80.5962, SE = 44.6616, p = 0.071

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -15.8769, p = 0.629
  Male (n=79):   beta = -6.8879, p = 0.870

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.622
  Shapiro-Wilk p: < 0.001


Outcome: PRP IIV Slope (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0308, p = 0.105
  Step 2 (UCLA):        Delta R^2 = 0.0026, p = 0.460 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0137, p = 0.102 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 19.8460, SE = 26.7819, t = 0.74, p = 0.459

UCLA x Gender Interaction (Model 3):
  beta = -68.4038, SE = 41.6592, p = 0.101

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 43.2411, p = 0.233
  Male (n=79):   beta = -6.0465, p = 0.885

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.577
  Shapiro-Wilk p: 0.477


Outcome: PRP IIV Residual SD (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0028, p = 0.900
  Step 2 (UCLA):        Delta R^2 = 0.0024, p = 0.474 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0083, p = 0.222 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 5.9289, SE = 8.2702, t = 0.72, p = 0.473

UCLA x Gender Interaction (Model 3):
  beta = 16.5055, SE = 13.4702, p = 0.220

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 2.0806, p = 0.843
  Male (n=79):   beta = 6.9481, p = 0.604

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.447
  Shapiro-Wilk p: 0.120


Outcome: PRP IIV Raw CV (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0315, p = 0.099
  Step 2 (UCLA):        Delta R^2 = 0.0010, p = 0.680 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.970 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0026, SE = 0.0062, t = 0.41, p = 0.679

UCLA x Gender Interaction (Model 3):
  beta = -0.0003, SE = 0.0094, p = 0.970

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0015, p = 0.851
  Male (n=79):   beta = 0.0108, p = 0.356

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.755
  Shapiro-Wilk p: 0.151


Outcome: PRP IIV R-squared (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0189, p = 0.292
  Step 2 (UCLA):        Delta R^2 = 0.0020, p = 0.495 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0008, p = 0.699 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0032, SE = 0.0047, t = -0.68, p = 0.494

UCLA x Gender Interaction (Model 3):
  beta = 0.0030, SE = 0.0078, p = 0.699

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0017, p = 0.772
  Male (n=79):   beta = -0.0073, p = 0.377

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.323
  Shapiro-Wilk p: < 0.001


Outcome: PRP Post-Error CV Reduction (N = 89)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0560, p = 0.181
  Step 2 (UCLA):        Delta R^2 = 0.0046, p = 0.475 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0053, p = 0.477 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0146, SE = 0.0204, t = -0.72, p = 0.473

UCLA x Gender Interaction (Model 3):
  beta = 0.0235, SE = 0.0329, p = 0.475

Gender-Stratified UCLA Effects:
  Female (n=53): beta = -0.0223, p = 0.309
  Male (n=36):   beta = -0.0048, p = 0.925

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.363
  Shapiro-Wilk p: 0.154


Outcome: PRP Post-Error Accuracy (N = 89)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0277, p = 0.488
  Step 2 (UCLA):        Delta R^2 = 0.0212, p = 0.236 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0111, p = 0.431 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0234, SE = 0.0196, t = 1.19, p = 0.233

UCLA x Gender Interaction (Model 3):
  beta = -0.0253, SE = 0.0320, p = 0.428

Gender-Stratified UCLA Effects:
  Female (n=53): beta = 0.0320, p = 0.187
  Male (n=36):   beta = 0.0045, p = 0.904

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.300
  Shapiro-Wilk p: < 0.001


Outcome: PRP Post-Error Accuracy Diff (N = 89)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0424, p = 0.286
  Step 2 (UCLA):        Delta R^2 = 0.0286, p = 0.162 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0147, p = 0.368 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0279, SE = 0.0197, t = 1.41, p = 0.158

UCLA x Gender Interaction (Model 3):
  beta = -0.0300, SE = 0.0331, p = 0.365

Gender-Stratified UCLA Effects:
  Female (n=53): beta = 0.0378, p = 0.114
  Male (n=36):   beta = 0.0089, p = 0.822

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.445
  Shapiro-Wilk p: < 0.001


Outcome: PRP Post-Error Recovery Rate (N = 89)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0277, p = 0.488
  Step 2 (UCLA):        Delta R^2 = 0.0212, p = 0.236 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0111, p = 0.431 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0234, SE = 0.0196, t = 1.19, p = 0.233

UCLA x Gender Interaction (Model 3):
  beta = -0.0253, SE = 0.0320, p = 0.428

Gender-Stratified UCLA Effects:
  Female (n=53): beta = 0.0320, p = 0.187
  Male (n=36):   beta = 0.0045, p = 0.904

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.300
  Shapiro-Wilk p: < 0.001


Outcome: PRP Adaptive PES Flag (N = 89)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0029, p = 0.969
  Step 2 (UCLA):        Delta R^2 = 0.0473, p = 0.041 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0014, p = 0.749 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.1422, SE = 0.0683, t = 2.08, p = 0.037

UCLA x Gender Interaction (Model 3):
  beta = -0.0370, SE = 0.1155, p = 0.749

Gender-Stratified UCLA Effects:
  Female (n=53): beta = 0.1181, p = 0.188
  Male (n=36):   beta = 0.1421, p = 0.300

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.352
  Shapiro-Wilk p: < 0.001


Outcome: PRP Maladaptive PES Flag (N = 89)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0054, p = 0.924
  Step 2 (UCLA):        Delta R^2 = 0.0212, p = 0.193 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.992 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0887, SE = 0.0675, t = -1.31, p = 0.189

UCLA x Gender Interaction (Model 3):
  beta = 0.0011, SE = 0.1089, p = 0.992

Gender-Stratified UCLA Effects:
  Female (n=53): beta = -0.0819, p = 0.291
  Male (n=36):   beta = -0.0936, p = 0.486

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.793
  Shapiro-Wilk p: < 0.001


Outcome: PRP Error Awareness Index (N = 89)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0413, p = 0.312
  Step 2 (UCLA):        Delta R^2 = 0.0088, p = 0.420 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0034, p = 0.635 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.1016, SE = 0.1254, t = 0.81, p = 0.418

UCLA x Gender Interaction (Model 3):
  beta = -0.0941, SE = 0.1972, p = 0.633

Gender-Stratified UCLA Effects:
  Female (n=53): beta = 0.1342, p = 0.400
  Male (n=36):   beta = 0.0155, p = 0.944

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.211
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Mean RT (All) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0234, p = 0.169
  Step 2 (UCLA):        Delta R^2 = 0.0004, p = 0.786 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0096, p = 0.234 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 6.2198, SE = 22.9205, t = 0.27, p = 0.786

UCLA x Gender Interaction (Model 3):
  beta = 46.3943, SE = 38.8805, p = 0.233

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 5.7437, p = 0.841
  Male (n=79):   beta = -9.9111, p = 0.803

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.878
  Shapiro-Wilk p: 0.002


Outcome: PRP T2 Accuracy (All) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0045, p = 0.831
  Step 2 (UCLA):        Delta R^2 = 0.0137, p = 0.135 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0008, p = 0.651 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0036, SE = 0.0024, t = -1.50, p = 0.133

UCLA x Gender Interaction (Model 3):
  beta = 0.0013, SE = 0.0029, p = 0.651

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0048, p = 0.114
  Male (n=79):   beta = -0.0014, p = 0.733

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.607
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Error Rate (All) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0045, p = 0.831
  Step 2 (UCLA):        Delta R^2 = 0.0137, p = 0.135 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0008, p = 0.651 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0036, SE = 0.0024, t = 1.50, p = 0.133

UCLA x Gender Interaction (Model 3):
  beta = -0.0013, SE = 0.0029, p = 0.651

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0048, p = 0.114
  Male (n=79):   beta = 0.0014, p = 0.733

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.607
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Inverse Efficiency Score (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0239, p = 0.161
  Step 2 (UCLA):        Delta R^2 = 0.0010, p = 0.666 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0091, p = 0.246 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 10.0365, SE = 23.2270, t = 0.43, p = 0.666

UCLA x Gender Interaction (Model 3):
  beta = 46.2423, SE = 39.7158, p = 0.244

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 10.9485, p = 0.713
  Male (n=79):   beta = -9.2412, p = 0.814

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.840
  Shapiro-Wilk p: 0.001


Outcome: PRP Pre-Error RT Slope (Mean) (N = 90)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.1243, p = 0.009
  Step 2 (UCLA):        Delta R^2 = 0.0151, p = 0.311 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0002, p = 0.919 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -23.7776, SE = 23.3106, t = -1.02, p = 0.308

UCLA x Gender Interaction (Model 3):
  beta = -3.8665, SE = 37.8482, p = 0.919

Gender-Stratified UCLA Effects:
  Female (n=55): beta = -24.4708, p = 0.451
  Male (n=35):   beta = -16.6019, p = 0.571

Diagnostics:
  VIF max: 2.57
  Breusch-Pagan p: 0.323
  Shapiro-Wilk p: 0.011


Outcome: PRP Pre-Error RT Slope (SD) (N = 90)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0060, p = 0.914
  Step 2 (UCLA):        Delta R^2 = 0.0044, p = 0.587 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0002, p = 0.912 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -10.5174, SE = 19.2627, t = -0.55, p = 0.585

UCLA x Gender Interaction (Model 3):
  beta = 3.2576, SE = 29.5022, p = 0.912

Gender-Stratified UCLA Effects:
  Female (n=55): beta = -30.1669, p = 0.122
  Male (n=35):   beta = 23.4632, p = 0.552

Diagnostics:
  VIF max: 2.57
  Breusch-Pagan p: 0.459
  Shapiro-Wilk p: < 0.001


Outcome: PRP Pre-Error Events (N) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0047, p = 0.821
  Step 2 (UCLA):        Delta R^2 = 0.0122, p = 0.150 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0020, p = 0.469 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.3979, SE = 0.2754, t = 1.44, p = 0.149

UCLA x Gender Interaction (Model 3):
  beta = -0.2385, SE = 0.3288, p = 0.468

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.5785, p = 0.096
  Male (n=79):   beta = 0.0793, p = 0.866

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.753
  Shapiro-Wilk p: < 0.001


Outcome: PRP Recovery RT Lag1 (N = 93)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0480, p = 0.182
  Step 2 (UCLA):        Delta R^2 = 0.0032, p = 0.591 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0308, p = 0.083 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 26.1460, SE = 48.5295, t = 0.54, p = 0.590

UCLA x Gender Interaction (Model 3):
  beta = 120.3403, SE = 68.5479, p = 0.079

Gender-Stratified UCLA Effects:
  Female (n=55): beta = -4.6216, p = 0.938
  Male (n=38):   beta = 13.3720, p = 0.856

Diagnostics:
  VIF max: 2.54
  Breusch-Pagan p: 0.111
  Shapiro-Wilk p: 0.020


Outcome: PRP Recovery RT Lag2 (N = 93)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0563, p = 0.137
  Step 2 (UCLA):        Delta R^2 = 0.0048, p = 0.500 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0027, p = 0.634 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -28.1423, SE = 41.5233, t = -0.68, p = 0.498

UCLA x Gender Interaction (Model 3):
  beta = -31.0827, SE = 65.0730, p = 0.633

Gender-Stratified UCLA Effects:
  Female (n=55): beta = -18.0710, p = 0.722
  Male (n=38):   beta = -92.2291, p = 0.269

Diagnostics:
  VIF max: 2.54
  Breusch-Pagan p: 0.076
  Shapiro-Wilk p: 0.354


Outcome: PRP Recovery RT Lag3 (N = 93)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0928, p = 0.031
  Step 2 (UCLA):        Delta R^2 = 0.0009, p = 0.787 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0319, p = 0.115 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 11.9476, SE = 44.1472, t = 0.27, p = 0.787

UCLA x Gender Interaction (Model 3):
  beta = 105.4356, SE = 66.1496, p = 0.111

Gender-Stratified UCLA Effects:
  Female (n=55): beta = -49.4809, p = 0.182
  Male (n=38):   beta = 30.4840, p = 0.671

Diagnostics:
  VIF max: 2.54
  Breusch-Pagan p: 0.446
  Shapiro-Wilk p: 0.120


Outcome: PRP Recovery RT Lag4 (N = 93)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0543, p = 0.159
  Step 2 (UCLA):        Delta R^2 = 0.0004, p = 0.866 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0792, p = 0.027 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 7.9446, SE = 46.7931, t = 0.17, p = 0.865

UCLA x Gender Interaction (Model 3):
  beta = 177.4490, SE = 79.0687, p = 0.025

Gender-Stratified UCLA Effects:
  Female (n=55): beta = -26.2811, p = 0.568
  Male (n=38):   beta = 7.0582, p = 0.942

Diagnostics:
  VIF max: 2.54
  Breusch-Pagan p: 0.614
  Shapiro-Wilk p: 0.065


Outcome: PRP Recovery RT Lag5 (N = 93)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0514, p = 0.188
  Step 2 (UCLA):        Delta R^2 = 0.0034, p = 0.582 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0608, p = 0.026 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -24.5032, SE = 44.3505, t = -0.55, p = 0.581

UCLA x Gender Interaction (Model 3):
  beta = 155.4800, SE = 68.3818, p = 0.023

Gender-Stratified UCLA Effects:
  Female (n=55): beta = -86.8985, p = 0.069
  Male (n=38):   beta = 54.4055, p = 0.564

Diagnostics:
  VIF max: 2.54
  Breusch-Pagan p: 0.918
  Shapiro-Wilk p: < 0.001


Outcome: PRP Recovery Accuracy Lag1 (N = 93)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0330, p = 0.388
  Step 2 (UCLA):        Delta R^2 = 0.0320, p = 0.131 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0038, p = 0.642 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0300, SE = 0.0197, t = 1.52, p = 0.128

UCLA x Gender Interaction (Model 3):
  beta = -0.0153, SE = 0.0329, p = 0.641

Gender-Stratified UCLA Effects:
  Female (n=55): beta = 0.0337, p = 0.136
  Male (n=38):   beta = 0.0285, p = 0.509

Diagnostics:
  VIF max: 2.54
  Breusch-Pagan p: 0.408
  Shapiro-Wilk p: < 0.001


Outcome: PRP Recovery Accuracy Lag2 (N = 93)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0126, p = 0.774
  Step 2 (UCLA):        Delta R^2 = 0.0035, p = 0.554 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0051, p = 0.397 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0046, SE = 0.0078, t = 0.59, p = 0.553

UCLA x Gender Interaction (Model 3):
  beta = -0.0084, SE = 0.0098, p = 0.395

Gender-Stratified UCLA Effects:
  Female (n=55): beta = 0.0102, p = 0.345
  Male (n=38):   beta = -0.0080, p = 0.455

Diagnostics:
  VIF max: 2.54
  Breusch-Pagan p: 0.829
  Shapiro-Wilk p: < 0.001


Outcome: PRP Recovery Accuracy Lag3 (N = 93)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0023, p = 0.977
  Step 2 (UCLA):        Delta R^2 = 0.0028, p = 0.640 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0353, p = 0.193 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0065, SE = 0.0138, t = -0.47, p = 0.638

UCLA x Gender Interaction (Model 3):
  beta = -0.0341, SE = 0.0259, p = 0.189

Gender-Stratified UCLA Effects:
  Female (n=55): beta = 0.0063, p = 0.646
  Male (n=38):   beta = -0.0307, p = 0.416

Diagnostics:
  VIF max: 2.54
  Breusch-Pagan p: 0.474
  Shapiro-Wilk p: < 0.001


Outcome: PRP Recovery Accuracy Lag4 (N = 93)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0110, p = 0.802
  Step 2 (UCLA):        Delta R^2 = 0.0201, p = 0.229 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0019, p = 0.654 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0146, SE = 0.0120, t = 1.21, p = 0.225

UCLA x Gender Interaction (Model 3):
  beta = -0.0067, SE = 0.0149, p = 0.653

Gender-Stratified UCLA Effects:
  Female (n=55): beta = 0.0172, p = 0.326
  Male (n=38):   beta = 0.0099, p = 0.275

Diagnostics:
  VIF max: 2.54
  Breusch-Pagan p: 0.873
  Shapiro-Wilk p: < 0.001


Outcome: PRP Recovery Accuracy Lag5 (N = 93)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0283, p = 0.462
  Step 2 (UCLA):        Delta R^2 = 0.0398, p = 0.075 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0021, p = 0.612 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0161, SE = 0.0089, t = -1.80, p = 0.071

UCLA x Gender Interaction (Model 3):
  beta = 0.0055, SE = 0.0109, p = 0.611

Gender-Stratified UCLA Effects:
  Female (n=55): beta = -0.0212, p = 0.088
  Male (n=38):   beta = -0.0076, p = 0.598

Diagnostics:
  VIF max: 2.54
  Breusch-Pagan p: 0.276
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Mean RT (SOA 50) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0227, p = 0.176
  Step 2 (UCLA):        Delta R^2 = 0.0025, p = 0.498 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0172, p = 0.114 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 18.1278, SE = 26.6834, t = 0.68, p = 0.497

UCLA x Gender Interaction (Model 3):
  beta = 70.6995, SE = 44.5184, p = 0.112

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 13.6760, p = 0.681
  Male (n=79):   beta = 1.9760, p = 0.964

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.318
  Shapiro-Wilk p: 0.001


Outcome: PRP T2 Mean RT (SOA 150) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0128, p = 0.435
  Step 2 (UCLA):        Delta R^2 = 0.0032, p = 0.438 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0084, p = 0.271 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 20.6044, SE = 26.5135, t = 0.78, p = 0.437

UCLA x Gender Interaction (Model 3):
  beta = 49.9507, SE = 45.2766, p = 0.270

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 18.5019, p = 0.563
  Male (n=79):   beta = 3.4072, p = 0.942

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.939
  Shapiro-Wilk p: 0.006


Outcome: PRP T2 Mean RT (SOA 300) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0217, p = 0.198
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.903 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0090, p = 0.223 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -3.4449, SE = 28.1244, t = -0.12, p = 0.903

UCLA x Gender Interaction (Model 3):
  beta = 54.8695, SE = 44.8646, p = 0.221

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -5.5109, p = 0.877
  Male (n=79):   beta = -17.0238, p = 0.735

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.872
  Shapiro-Wilk p: 0.006


Outcome: PRP T2 Mean RT (SOA 600) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0273, p = 0.123
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.918 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0061, p = 0.330 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 2.4508, SE = 23.6497, t = 0.10, p = 0.917

UCLA x Gender Interaction (Model 3):
  beta = 38.1932, SE = 39.0877, p = 0.329

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 5.3211, p = 0.858
  Male (n=79):   beta = -16.6050, p = 0.689

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.959
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Mean RT (SOA 1200) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0320, p = 0.088
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.938 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0039, p = 0.465 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -1.3450, SE = 17.1833, t = -0.08, p = 0.938

UCLA x Gender Interaction (Model 3):
  beta = 23.0351, SE = 31.4302, p = 0.464

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.2388, p = 0.991
  Male (n=79):   beta = -12.5966, p = 0.670

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.716
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Median RT (SOA 50) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0242, p = 0.153
  Step 2 (UCLA):        Delta R^2 = 0.0033, p = 0.456 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0243, p = 0.067 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 21.4511, SE = 28.7281, t = 0.75, p = 0.455

UCLA x Gender Interaction (Model 3):
  beta = 87.0121, SE = 47.2362, p = 0.065

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 13.0534, p = 0.721
  Male (n=79):   beta = 6.1697, p = 0.891

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.534
  Shapiro-Wilk p: 0.001


Outcome: PRP T2 Median RT (SOA 150) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0139, p = 0.399
  Step 2 (UCLA):        Delta R^2 = 0.0036, p = 0.416 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0122, p = 0.196 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 23.6065, SE = 28.9873, t = 0.81, p = 0.415

UCLA x Gender Interaction (Model 3):
  beta = 64.7075, SE = 49.8341, p = 0.194

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 17.9024, p = 0.597
  Male (n=79):   beta = 8.5168, p = 0.872

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.893
  Shapiro-Wilk p: 0.001


Outcome: PRP T2 Median RT (SOA 300) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0265, p = 0.125
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.971 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0088, p = 0.254 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -1.1421, SE = 31.2521, t = -0.04, p = 0.971

UCLA x Gender Interaction (Model 3):
  beta = 56.8052, SE = 49.6416, p = 0.252

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -3.4956, p = 0.926
  Male (n=79):   beta = -15.1880, p = 0.797

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.608
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Median RT (SOA 600) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0312, p = 0.091
  Step 2 (UCLA):        Delta R^2 = 0.0003, p = 0.807 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0052, p = 0.376 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 5.7417, SE = 23.4370, t = 0.24, p = 0.806

UCLA x Gender Interaction (Model 3):
  beta = 35.5235, SE = 40.0677, p = 0.375

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 17.3903, p = 0.561
  Male (n=79):   beta = -30.0136, p = 0.473

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.895
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Median RT (SOA 1200) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0372, p = 0.055
  Step 2 (UCLA):        Delta R^2 = 0.0007, p = 0.703 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0055, p = 0.412 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 5.8438, SE = 15.3084, t = 0.38, p = 0.703

UCLA x Gender Interaction (Model 3):
  beta = 23.7067, SE = 28.8546, p = 0.411

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 4.9515, p = 0.801
  Male (n=79):   beta = 0.4251, p = 0.987

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.327
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 RT SD (SOA 50) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0025, p = 0.917
  Step 2 (UCLA):        Delta R^2 = 0.0047, p = 0.331 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0030, p = 0.463 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 9.9803, SE = 10.2364, t = 0.97, p = 0.330

UCLA x Gender Interaction (Model 3):
  beta = 11.7918, SE = 16.0503, p = 0.463

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 9.5986, p = 0.478
  Male (n=79):   beta = 5.5112, p = 0.723

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.985
  Shapiro-Wilk p: 0.321


Outcome: PRP T2 RT SD (SOA 150) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0011, p = 0.973
  Step 2 (UCLA):        Delta R^2 = 0.0028, p = 0.430 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0020, p = 0.554 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 7.9746, SE = 10.0741, t = 0.79, p = 0.429

UCLA x Gender Interaction (Model 3):
  beta = 10.2655, SE = 17.3298, p = 0.554

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 5.0618, p = 0.699
  Male (n=79):   beta = 8.0206, p = 0.633

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.642
  Shapiro-Wilk p: 0.073


Outcome: PRP T2 RT SD (SOA 300) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0215, p = 0.232
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.947 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0021, p = 0.503 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.7236, SE = 10.8133, t = -0.07, p = 0.947

UCLA x Gender Interaction (Model 3):
  beta = 10.6945, SE = 15.9415, p = 0.502

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0906, p = 0.995
  Male (n=79):   beta = -5.5876, p = 0.762

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.665
  Shapiro-Wilk p: 0.099


Outcome: PRP T2 RT SD (SOA 600) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0157, p = 0.359
  Step 2 (UCLA):        Delta R^2 = 0.0004, p = 0.797 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0041, p = 0.394 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 3.4350, SE = 13.3036, t = 0.26, p = 0.796

UCLA x Gender Interaction (Model 3):
  beta = 17.3155, SE = 20.2504, p = 0.393

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -4.6581, p = 0.781
  Male (n=79):   beta = 13.9328, p = 0.521

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.175
  Shapiro-Wilk p: 0.089


Outcome: PRP T2 RT SD (SOA 1200) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0124, p = 0.474
  Step 2 (UCLA):        Delta R^2 = 0.0017, p = 0.527 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0019, p = 0.545 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -6.5708, SE = 10.3803, t = -0.63, p = 0.527

UCLA x Gender Interaction (Model 3):
  beta = 10.4820, SE = 17.2727, p = 0.544

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -5.4819, p = 0.699
  Male (n=79):   beta = -12.3893, p = 0.440

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.843
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Mean RT (SOA 50) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0146, p = 0.391
  Step 2 (UCLA):        Delta R^2 = 0.0003, p = 0.810 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0262, p = 0.110 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 5.4899, SE = 22.8149, t = 0.24, p = 0.810

UCLA x Gender Interaction (Model 3):
  beta = 73.4364, SE = 45.7029, p = 0.108

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 1.4824, p = 0.955
  Male (n=79):   beta = -9.2224, p = 0.849

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: < 0.001
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Mean RT (SOA 150) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0081, p = 0.648
  Step 2 (UCLA):        Delta R^2 = 0.0005, p = 0.771 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0193, p = 0.164 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 6.9637, SE = 23.9322, t = 0.29, p = 0.771

UCLA x Gender Interaction (Model 3):
  beta = 64.7636, SE = 46.3432, p = 0.162

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 2.0200, p = 0.939
  Male (n=79):   beta = -6.9970, p = 0.892

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.088
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Mean RT (SOA 300) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0140, p = 0.414
  Step 2 (UCLA):        Delta R^2 = 0.0014, p = 0.613 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0196, p = 0.139 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -12.5206, SE = 24.7358, t = -0.51, p = 0.613

UCLA x Gender Interaction (Model 3):
  beta = 69.8634, SE = 46.9889, p = 0.137

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -18.7069, p = 0.526
  Male (n=79):   beta = -20.1848, p = 0.695

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.289
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Mean RT (SOA 600) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0137, p = 0.433
  Step 2 (UCLA):        Delta R^2 = 0.0020, p = 0.565 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0242, p = 0.091 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -15.0768, SE = 26.1465, t = -0.58, p = 0.564

UCLA x Gender Interaction (Model 3):
  beta = 78.8362, SE = 46.3870, p = 0.089

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -22.8686, p = 0.459
  Male (n=79):   beta = -23.0391, p = 0.669

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.206
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Mean RT (SOA 1200) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0099, p = 0.581
  Step 2 (UCLA):        Delta R^2 = 0.0074, p = 0.224 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0098, p = 0.274 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -40.2023, SE = 32.9448, t = -1.22, p = 0.222

UCLA x Gender Interaction (Model 3):
  beta = 68.7745, SE = 62.7307, p = 0.273

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -31.7782, p = 0.441
  Male (n=79):   beta = -77.7014, p = 0.260

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.144
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Median RT (SOA 50) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0181, p = 0.294
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.927 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0307, p = 0.092 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 2.1726, SE = 23.7842, t = 0.09, p = 0.927

UCLA x Gender Interaction (Model 3):
  beta = 81.2792, SE = 47.9566, p = 0.090

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -6.7356, p = 0.802
  Male (n=79):   beta = -5.9762, p = 0.906

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: < 0.001
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Median RT (SOA 150) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0159, p = 0.357
  Step 2 (UCLA):        Delta R^2 = 0.0004, p = 0.807 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0210, p = 0.164 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 6.1971, SE = 25.3395, t = 0.24, p = 0.807

UCLA x Gender Interaction (Model 3):
  beta = 71.2935, SE = 50.9731, p = 0.162

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 3.3138, p = 0.905
  Male (n=79):   beta = -13.9915, p = 0.798

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.114
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Median RT (SOA 300) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0139, p = 0.415
  Step 2 (UCLA):        Delta R^2 = 0.0022, p = 0.552 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0232, p = 0.113 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -16.4853, SE = 27.6375, t = -0.60, p = 0.551

UCLA x Gender Interaction (Model 3):
  beta = 79.8925, SE = 50.1225, p = 0.111

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -27.8499, p = 0.379
  Male (n=79):   beta = -17.7063, p = 0.757

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.384
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Median RT (SOA 600) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0176, p = 0.319
  Step 2 (UCLA):        Delta R^2 = 0.0039, p = 0.424 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0194, p = 0.152 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -22.0548, SE = 27.5120, t = -0.80, p = 0.423

UCLA x Gender Interaction (Model 3):
  beta = 73.5720, SE = 51.1306, p = 0.150

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -21.5376, p = 0.504
  Male (n=79):   beta = -43.6659, p = 0.467

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.168
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Median RT (SOA 1200) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0098, p = 0.587
  Step 2 (UCLA):        Delta R^2 = 0.0063, p = 0.251 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0074, p = 0.308 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -39.4982, SE = 34.2978, t = -1.15, p = 0.249

UCLA x Gender Interaction (Model 3):
  beta = 64.2139, SE = 62.8610, p = 0.307

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -29.1095, p = 0.507
  Male (n=79):   beta = -80.2550, p = 0.246

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.342
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 RT SD (SOA 50) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0042, p = 0.842
  Step 2 (UCLA):        Delta R^2 = 0.0031, p = 0.427 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0100, p = 0.189 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 7.5385, SE = 9.4705, t = 0.80, p = 0.426

UCLA x Gender Interaction (Model 3):
  beta = 20.2177, SE = 15.3300, p = 0.187

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 5.6445, p = 0.646
  Male (n=79):   beta = 3.9586, p = 0.798

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.296
  Shapiro-Wilk p: 0.280


Outcome: PRP T1 RT SD (SOA 150) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0006, p = 0.990
  Step 2 (UCLA):        Delta R^2 = 0.0036, p = 0.378 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0099, p = 0.222 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 7.9648, SE = 9.0211, t = 0.88, p = 0.377

UCLA x Gender Interaction (Model 3):
  beta = 19.6943, SE = 16.0670, p = 0.220

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 1.4733, p = 0.889
  Male (n=79):   beta = 14.3655, p = 0.395

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.199
  Shapiro-Wilk p: 0.004


Outcome: PRP T1 RT SD (SOA 300) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0259, p = 0.160
  Step 2 (UCLA):        Delta R^2 = 0.0007, p = 0.675 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0053, p = 0.287 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 4.0569, SE = 9.6528, t = 0.42, p = 0.674

UCLA x Gender Interaction (Model 3):
  beta = 16.1861, SE = 15.1548, p = 0.285

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 3.0261, p = 0.808
  Male (n=79):   beta = 3.2739, p = 0.844

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.509
  Shapiro-Wilk p: 0.017


Outcome: PRP T1 RT SD (SOA 600) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0138, p = 0.428
  Step 2 (UCLA):        Delta R^2 = 0.0009, p = 0.701 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0135, p = 0.129 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 4.9668, SE = 12.9123, t = 0.38, p = 0.700

UCLA x Gender Interaction (Model 3):
  beta = 27.9678, SE = 18.3338, p = 0.127

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -7.4594, p = 0.650
  Male (n=79):   beta = 20.9822, p = 0.298

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.263
  Shapiro-Wilk p: 0.321


Outcome: PRP T1 RT SD (SOA 1200) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0140, p = 0.431
  Step 2 (UCLA):        Delta R^2 = 0.0073, p = 0.235 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.907 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -16.6980, SE = 14.0036, t = -1.19, p = 0.233

UCLA x Gender Interaction (Model 3):
  beta = -2.5438, SE = 21.8435, p = 0.907

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -19.6939, p = 0.264
  Male (n=79):   beta = -10.5184, p = 0.662

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.062
  Shapiro-Wilk p: 0.005


Outcome: PRP T1 Accuracy (SOA 50) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0079, p = 0.668
  Step 2 (UCLA):        Delta R^2 = 0.0093, p = 0.154 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0086, p = 0.207 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0049, SE = 0.0034, t = -1.43, p = 0.153

UCLA x Gender Interaction (Model 3):
  beta = -0.0070, SE = 0.0056, p = 0.205

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0019, p = 0.669
  Male (n=79):   beta = -0.0096, p = 0.105

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.456
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Accuracy (SOA 150) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0100, p = 0.576
  Step 2 (UCLA):        Delta R^2 = 0.0002, p = 0.868 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0271, p = 0.033 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0007, SE = 0.0043, t = -0.17, p = 0.868

UCLA x Gender Interaction (Model 3):
  beta = -0.0141, SE = 0.0066, p = 0.032

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0031, p = 0.551
  Male (n=79):   beta = -0.0052, p = 0.510

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.136
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Accuracy (SOA 300) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0109, p = 0.533
  Step 2 (UCLA):        Delta R^2 = 0.0008, p = 0.727 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0027, p = 0.480 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0012, SE = 0.0034, t = 0.35, p = 0.727

UCLA x Gender Interaction (Model 3):
  beta = -0.0033, SE = 0.0047, p = 0.479

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0015, p = 0.756
  Male (n=79):   beta = 0.0015, p = 0.777

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.343
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Accuracy (SOA 600) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0224, p = 0.212
  Step 2 (UCLA):        Delta R^2 = 0.0010, p = 0.664 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0004, p = 0.781 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0013, SE = 0.0030, t = 0.44, p = 0.664

UCLA x Gender Interaction (Model 3):
  beta = -0.0013, SE = 0.0045, p = 0.781

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0014, p = 0.758
  Male (n=79):   beta = 0.0022, p = 0.501

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.418
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Accuracy (SOA 1200) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0540, p = 0.011
  Step 2 (UCLA):        Delta R^2 = 0.0069, p = 0.311 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.921 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0029, SE = 0.0028, t = -1.02, p = 0.310

UCLA x Gender Interaction (Model 3):
  beta = 0.0004, SE = 0.0041, p = 0.920

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0021, p = 0.575
  Male (n=79):   beta = -0.0031, p = 0.507

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.411
  Shapiro-Wilk p: < 0.001


Outcome: PRP RT1-RT2 Coupling (SOA 50) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0134, p = 0.432
  Step 2 (UCLA):        Delta R^2 = 0.0010, p = 0.613 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0068, p = 0.215 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0037, SE = 0.0073, t = 0.51, p = 0.612

UCLA x Gender Interaction (Model 3):
  beta = 0.0146, SE = 0.0117, p = 0.213

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0043, p = 0.611
  Male (n=79):   beta = -0.0024, p = 0.861

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.567
  Shapiro-Wilk p: < 0.001


Outcome: PRP RT1-RT2 Coupling (SOA 150) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0193, p = 0.279
  Step 2 (UCLA):        Delta R^2 = 0.0037, p = 0.404 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0339, p = 0.002 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0091, SE = 0.0109, t = -0.84, p = 0.403

UCLA x Gender Interaction (Model 3):
  beta = 0.0412, SE = 0.0133, p = 0.002

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0248, p = 0.077
  Male (n=79):   beta = 0.0094, p = 0.506

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.544
  Shapiro-Wilk p: < 0.001


Outcome: PRP RT1-RT2 Coupling (SOA 300) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0050, p = 0.804
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.970 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0195, p = 0.042 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0003, SE = 0.0080, t = 0.04, p = 0.970

UCLA x Gender Interaction (Model 3):
  beta = 0.0242, SE = 0.0119, p = 0.041

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0015, p = 0.884
  Male (n=79):   beta = -0.0036, p = 0.787

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.932
  Shapiro-Wilk p: < 0.001


Outcome: PRP RT1-RT2 Coupling (SOA 600) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0218, p = 0.217
  Step 2 (UCLA):        Delta R^2 = 0.0040, p = 0.391 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0646, p = < 0.001 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0104, SE = 0.0122, t = -0.86, p = 0.390

UCLA x Gender Interaction (Model 3):
  beta = 0.0626, SE = 0.0177, p = < 0.001

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0324, p = 0.020
  Male (n=79):   beta = 0.0171, p = 0.481

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.035
  Shapiro-Wilk p: < 0.001


Outcome: PRP RT1-RT2 Coupling (SOA 1200) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0285, p = 0.128
  Step 2 (UCLA):        Delta R^2 = 0.0161, p = 0.054 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0005, p = 0.736 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0466, SE = 0.0240, t = -1.94, p = 0.052

UCLA x Gender Interaction (Model 3):
  beta = 0.0127, SE = 0.0376, p = 0.735

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0437, p = 0.121
  Male (n=79):   beta = -0.0526, p = 0.299

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.675
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian mu (short, correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0197, p = 0.242
  Step 2 (UCLA):        Delta R^2 = 0.0063, p = 0.312 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0076, p = 0.346 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 32.2562, SE = 31.8048, t = 1.01, p = 0.310

UCLA x Gender Interaction (Model 3):
  beta = 52.7864, SE = 55.8596, p = 0.345

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 32.7671, p = 0.412
  Male (n=79):   beta = 9.0119, p = 0.874

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.569
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (short, correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0190, p = 0.269
  Step 2 (UCLA):        Delta R^2 = 0.0156, p = 0.108 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0057, p = 0.349 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 19.8017, SE = 12.2744, t = 1.61, p = 0.107

UCLA x Gender Interaction (Model 3):
  beta = 17.8482, SE = 19.0151, p = 0.348

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 17.4754, p = 0.289
  Male (n=79):   beta = 16.0617, p = 0.387

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.556
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (short, correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0182, p = 0.305
  Step 2 (UCLA):        Delta R^2 = 0.0033, p = 0.444 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0011, p = 0.674 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -12.9072, SE = 16.8256, t = -0.77, p = 0.443

UCLA x Gender Interaction (Model 3):
  beta = 10.9594, SE = 25.9832, p = 0.673

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -18.0878, p = 0.412
  Male (n=79):   beta = -3.9951, p = 0.889

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.888
  Shapiro-Wilk p: 0.283


Outcome: PRP Ex-Gaussian mu (long, correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0319, p = 0.104
  Step 2 (UCLA):        Delta R^2 = 0.0014, p = 0.603 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0054, p = 0.390 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 6.6871, SE = 12.8258, t = 0.52, p = 0.602

UCLA x Gender Interaction (Model 3):
  beta = 19.8853, SE = 23.0729, p = 0.389

Gender-Stratified UCLA Effects:
  Female (n=114): beta = 4.4252, p = 0.794
  Male (n=79):   beta = 2.4079, p = 0.907

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.429
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (long, correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0368, p = 0.069
  Step 2 (UCLA):        Delta R^2 = 0.0043, p = 0.344 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0027, p = 0.462 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 5.4369, SE = 5.7298, t = 0.95, p = 0.343

UCLA x Gender Interaction (Model 3):
  beta = 6.4897, SE = 8.7960, p = 0.461

Gender-Stratified UCLA Effects:
  Female (n=114): beta = 0.7811, p = 0.917
  Male (n=79):   beta = 10.7323, p = 0.240

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.800
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (long, correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0224, p = 0.227
  Step 2 (UCLA):        Delta R^2 = 0.0008, p = 0.691 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0005, p = 0.766 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -5.2068, SE = 13.0881, t = -0.40, p = 0.691

UCLA x Gender Interaction (Model 3):
  beta = 6.2310, SE = 20.9126, p = 0.766

Gender-Stratified UCLA Effects:
  Female (n=114): beta = -3.3003, p = 0.850
  Male (n=79):   beta = -11.5578, p = 0.580

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.874
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian mu (overall, correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0349, p = 0.061
  Step 2 (UCLA):        Delta R^2 = 0.0002, p = 0.864 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0025, p = 0.586 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -4.8364, SE = 28.1248, t = -0.17, p = 0.863

UCLA x Gender Interaction (Model 3):
  beta = 27.0408, SE = 49.5185, p = 0.585

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 3.1287, p = 0.925
  Male (n=79):   beta = -29.7020, p = 0.616

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.488
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (overall, correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0233, p = 0.175
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.976 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0021, p = 0.610 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.4381, SE = 14.6489, t = 0.03, p = 0.976

UCLA x Gender Interaction (Model 3):
  beta = 12.9108, SE = 25.2733, p = 0.609

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 2.5843, p = 0.888
  Male (n=79):   beta = -8.4247, p = 0.765

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.320
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (overall, correct) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0158, p = 0.372
  Step 2 (UCLA):        Delta R^2 = 0.0034, p = 0.423 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0046, p = 0.404 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 11.6930, SE = 14.5475, t = 0.80, p = 0.422

UCLA x Gender Interaction (Model 3):
  beta = 20.3643, SE = 24.3635, p = 0.403

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 2.5957, p = 0.880
  Male (n=79):   beta = 21.4373, p = 0.468

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.864
  Shapiro-Wilk p: 0.511


Outcome: PRP Ex-Gaussian mu (SOA 50) (N = 196)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0425, p = 0.028
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.982 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0120, p = 0.215 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.7215, SE = 32.4771, t = -0.02, p = 0.982

UCLA x Gender Interaction (Model 3):
  beta = 70.0844, SE = 56.3253, p = 0.213

Gender-Stratified UCLA Effects:
  Female (n=119): beta = 5.2913, p = 0.897
  Male (n=77):   beta = -44.6462, p = 0.391

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.024
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 50) (N = 196)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0534, p = 0.012
  Step 2 (UCLA):        Delta R^2 = 0.0054, p = 0.332 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0115, p = 0.143 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 13.7661, SE = 14.1613, t = 0.97, p = 0.331

UCLA x Gender Interaction (Model 3):
  beta = 29.7016, SE = 20.2115, p = 0.142

Gender-Stratified UCLA Effects:
  Female (n=119): beta = 16.0252, p = 0.382
  Male (n=77):   beta = -6.4477, p = 0.732

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.158
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 50) (N = 196)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0374, p = 0.062
  Step 2 (UCLA):        Delta R^2 = 0.0004, p = 0.778 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.920 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 4.9973, SE = 17.7160, t = 0.28, p = 0.778

UCLA x Gender Interaction (Model 3):
  beta = -2.5166, SE = 25.0469, p = 0.920

Gender-Stratified UCLA Effects:
  Female (n=119): beta = -1.9146, p = 0.932
  Male (n=77):   beta = 26.3518, p = 0.396

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.543
  Shapiro-Wilk p: 0.011


Outcome: PRP Ex-Gaussian mu (SOA 150) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0177, p = 0.318
  Step 2 (UCLA):        Delta R^2 = 0.0055, p = 0.359 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0087, p = 0.309 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 31.9514, SE = 34.7460, t = 0.92, p = 0.358

UCLA x Gender Interaction (Model 3):
  beta = 60.1920, SE = 59.0437, p = 0.308

Gender-Stratified UCLA Effects:
  Female (n=115): beta = 23.0322, p = 0.571
  Male (n=79):   beta = 17.2965, p = 0.783

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.984
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 150) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0080, p = 0.672
  Step 2 (UCLA):        Delta R^2 = 0.0189, p = 0.073 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0005, p = 0.795 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 25.7431, SE = 14.2758, t = 1.80, p = 0.071

UCLA x Gender Interaction (Model 3):
  beta = 6.2724, SE = 24.1357, p = 0.795

Gender-Stratified UCLA Effects:
  Female (n=115): beta = 25.9334, p = 0.174
  Male (n=79):   beta = 17.4200, p = 0.406

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.705
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 150) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0045, p = 0.837
  Step 2 (UCLA):        Delta R^2 = 0.0025, p = 0.503 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.936 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -12.8623, SE = 19.1737, t = -0.67, p = 0.502

UCLA x Gender Interaction (Model 3):
  beta = -2.4202, SE = 30.1857, p = 0.936

Gender-Stratified UCLA Effects:
  Female (n=115): beta = -10.9758, p = 0.656
  Male (n=79):   beta = -12.4832, p = 0.696

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.534
  Shapiro-Wilk p: 0.002


Outcome: PRP Ex-Gaussian mu (SOA 300) (N = 200)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0503, p = 0.014
  Step 2 (UCLA):        Delta R^2 = 0.0009, p = 0.702 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0050, p = 0.396 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -12.4942, SE = 32.5671, t = -0.38, p = 0.701

UCLA x Gender Interaction (Model 3):
  beta = 42.7375, SE = 50.2337, p = 0.395

Gender-Stratified UCLA Effects:
  Female (n=121): beta = -16.1818, p = 0.672
  Male (n=79):   beta = -20.8228, p = 0.743

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.081
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 300) (N = 200)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0462, p = 0.025
  Step 2 (UCLA):        Delta R^2 = 0.0005, p = 0.753 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0039, p = 0.427 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -4.2946, SE = 13.6217, t = -0.32, p = 0.753

UCLA x Gender Interaction (Model 3):
  beta = 17.3410, SE = 21.7711, p = 0.426

Gender-Stratified UCLA Effects:
  Female (n=121): beta = -7.8696, p = 0.659
  Male (n=79):   beta = -4.2348, p = 0.852

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.098
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 300) (N = 200)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0277, p = 0.135
  Step 2 (UCLA):        Delta R^2 = 0.0009, p = 0.678 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0014, p = 0.607 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 6.9692, SE = 16.7571, t = 0.42, p = 0.677

UCLA x Gender Interaction (Model 3):
  beta = 12.6020, SE = 24.4701, p = 0.607

Gender-Stratified UCLA Effects:
  Female (n=121): beta = 6.0448, p = 0.775
  Male (n=79):   beta = 6.7092, p = 0.831

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.362
  Shapiro-Wilk p: 0.238


Outcome: PRP Ex-Gaussian mu (SOA 600) (N = 195)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0212, p = 0.239
  Step 2 (UCLA):        Delta R^2 = 0.0087, p = 0.147 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0122, p = 0.197 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -24.5520, SE = 16.8410, t = -1.46, p = 0.145

UCLA x Gender Interaction (Model 3):
  beta = 43.4792, SE = 33.6178, p = 0.196

Gender-Stratified UCLA Effects:
  Female (n=116): beta = -22.6201, p = 0.323
  Male (n=79):   beta = -42.8163, p = 0.125

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.121
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 600) (N = 195)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0052, p = 0.800
  Step 2 (UCLA):        Delta R^2 = 0.0175, p = 0.037 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0031, p = 0.528 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -18.2213, SE = 8.6889, t = -2.10, p = 0.036

UCLA x Gender Interaction (Model 3):
  beta = 11.4909, SE = 18.1909, p = 0.528

Gender-Stratified UCLA Effects:
  Female (n=116): beta = -13.1164, p = 0.279
  Male (n=79):   beta = -33.3113, p = 0.024

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.200
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 600) (N = 195)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0232, p = 0.210
  Step 2 (UCLA):        Delta R^2 = 0.0069, p = 0.273 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0003, p = 0.811 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 17.0487, SE = 15.5121, t = 1.10, p = 0.272

UCLA x Gender Interaction (Model 3):
  beta = 5.5797, SE = 23.2858, p = 0.811

Gender-Stratified UCLA Effects:
  Female (n=116): beta = 9.8751, p = 0.600
  Male (n=79):   beta = 26.3887, p = 0.332

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.593
  Shapiro-Wilk p: 0.154


Outcome: PRP Ex-Gaussian mu (SOA 1200) (N = 195)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0356, p = 0.074
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.924 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0048, p = 0.401 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 1.2248, SE = 12.7386, t = 0.10, p = 0.923

UCLA x Gender Interaction (Model 3):
  beta = 18.7230, SE = 22.2458, p = 0.400

Gender-Stratified UCLA Effects:
  Female (n=116): beta = -2.0150, p = 0.904
  Male (n=79):   beta = 0.2235, p = 0.991

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.752
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 1200) (N = 195)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0371, p = 0.066
  Step 2 (UCLA):        Delta R^2 = 0.0013, p = 0.582 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0010, p = 0.643 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 3.0394, SE = 5.5126, t = 0.55, p = 0.581

UCLA x Gender Interaction (Model 3):
  beta = 4.0372, SE = 8.6950, p = 0.642

Gender-Stratified UCLA Effects:
  Female (n=116): beta = -1.2592, p = 0.865
  Male (n=79):   beta = 8.8504, p = 0.322

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.813
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 1200) (N = 195)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0192, p = 0.288
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.874 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0019, p = 0.566 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -2.0495, SE = 12.9332, t = -0.16, p = 0.874

UCLA x Gender Interaction (Model 3):
  beta = 11.7576, SE = 20.4575, p = 0.565

Gender-Stratified UCLA Effects:
  Female (n=116): beta = -1.7355, p = 0.919
  Male (n=79):   beta = -8.9051, p = 0.666

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.696
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian mu (SOA 50, correct) (N = 191)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0479, p = 0.019
  Step 2 (UCLA):        Delta R^2 = 0.0003, p = 0.824 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0105, p = 0.254 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 7.3671, SE = 33.0645, t = 0.22, p = 0.824

UCLA x Gender Interaction (Model 3):
  beta = 66.0765, SE = 57.7395, p = 0.252

Gender-Stratified UCLA Effects:
  Female (n=115): beta = 12.7754, p = 0.763
  Male (n=76):   beta = -37.6827, p = 0.468

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.029
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 50, correct) (N = 191)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0592, p = 0.009
  Step 2 (UCLA):        Delta R^2 = 0.0065, p = 0.275 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0095, p = 0.182 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 15.3874, SE = 14.0556, t = 1.09, p = 0.274

UCLA x Gender Interaction (Model 3):
  beta = 27.5053, SE = 20.5077, p = 0.180

Gender-Stratified UCLA Effects:
  Female (n=115): beta = 15.7960, p = 0.385
  Male (n=76):   beta = -2.4909, p = 0.895

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.602
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 50, correct) (N = 191)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0423, p = 0.045
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.899 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.865 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -2.2794, SE = 17.8889, t = -0.13, p = 0.899

UCLA x Gender Interaction (Model 3):
  beta = 4.3455, SE = 25.5343, p = 0.865

Gender-Stratified UCLA Effects:
  Female (n=115): beta = -10.8127, p = 0.632
  Male (n=76):   beta = 22.7478, p = 0.481

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.565
  Shapiro-Wilk p: 0.013


Outcome: PRP Ex-Gaussian mu (SOA 150, correct) (N = 190)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0174, p = 0.339
  Step 2 (UCLA):        Delta R^2 = 0.0073, p = 0.296 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0080, p = 0.333 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 37.4611, SE = 35.7147, t = 1.05, p = 0.294

UCLA x Gender Interaction (Model 3):
  beta = 57.7781, SE = 59.4779, p = 0.331

Gender-Stratified UCLA Effects:
  Female (n=113): beta = 28.0847, p = 0.512
  Male (n=77):   beta = 19.4056, p = 0.764

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.985
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 150, correct) (N = 190)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0063, p = 0.758
  Step 2 (UCLA):        Delta R^2 = 0.0305, p = 0.023 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.914 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 33.2676, SE = 14.4596, t = 2.30, p = 0.021

UCLA x Gender Interaction (Model 3):
  beta = 2.6658, SE = 24.6003, p = 0.914

Gender-Stratified UCLA Effects:
  Female (n=113): beta = 35.4931, p = 0.073
  Male (n=77):   beta = 19.0212, p = 0.371

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.728
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 150, correct) (N = 190)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0033, p = 0.895
  Step 2 (UCLA):        Delta R^2 = 0.0063, p = 0.280 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.911 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -20.4613, SE = 18.8776, t = -1.08, p = 0.278

UCLA x Gender Interaction (Model 3):
  beta = 3.4261, SE = 30.6213, p = 0.911

Gender-Stratified UCLA Effects:
  Female (n=113): beta = -23.4803, p = 0.332
  Male (n=77):   beta = -10.3369, p = 0.751

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.671
  Shapiro-Wilk p: 0.004


Outcome: PRP Ex-Gaussian mu (SOA 300, correct) (N = 197)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0475, p = 0.020
  Step 2 (UCLA):        Delta R^2 = 0.0007, p = 0.748 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0079, p = 0.323 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -10.6214, SE = 32.9817, t = -0.32, p = 0.747

UCLA x Gender Interaction (Model 3):
  beta = 54.4271, SE = 54.9771, p = 0.322

Gender-Stratified UCLA Effects:
  Female (n=120): beta = -17.0297, p = 0.659
  Male (n=77):   beta = -17.1276, p = 0.797

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.073
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 300, correct) (N = 197)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0441, p = 0.033
  Step 2 (UCLA):        Delta R^2 = 0.0008, p = 0.710 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0065, p = 0.317 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -5.3115, SE = 14.2721, t = -0.37, p = 0.710

UCLA x Gender Interaction (Model 3):
  beta = 23.0319, SE = 22.9502, p = 0.316

Gender-Stratified UCLA Effects:
  Female (n=120): beta = -10.6264, p = 0.557
  Male (n=77):   beta = -3.7771, p = 0.880

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.096
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 300, correct) (N = 197)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0287, p = 0.128
  Step 2 (UCLA):        Delta R^2 = 0.0011, p = 0.653 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.916 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 7.6252, SE = 16.9539, t = 0.45, p = 0.653

UCLA x Gender Interaction (Model 3):
  beta = 2.7824, SE = 26.2387, p = 0.916

Gender-Stratified UCLA Effects:
  Female (n=120): beta = 8.0055, p = 0.711
  Male (n=77):   beta = 6.6838, p = 0.833

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.577
  Shapiro-Wilk p: 0.239


Outcome: PRP Ex-Gaussian mu (SOA 600, correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0208, p = 0.253
  Step 2 (UCLA):        Delta R^2 = 0.0097, p = 0.122 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0120, p = 0.203 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -26.5235, SE = 17.0808, t = -1.55, p = 0.120

UCLA x Gender Interaction (Model 3):
  beta = 44.2641, SE = 34.6178, p = 0.201

Gender-Stratified UCLA Effects:
  Female (n=115): beta = -23.8947, p = 0.304
  Male (n=78):   beta = -47.7850, p = 0.103

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.106
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 600, correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0062, p = 0.760
  Step 2 (UCLA):        Delta R^2 = 0.0232, p = 0.018 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0055, p = 0.415 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -20.8650, SE = 8.7359, t = -2.39, p = 0.017

UCLA x Gender Interaction (Model 3):
  beta = 15.1690, SE = 18.5638, p = 0.414

Gender-Stratified UCLA Effects:
  Female (n=115): beta = -16.8988, p = 0.170
  Male (n=78):   beta = -35.5311, p = 0.017

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.178
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 600, correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0219, p = 0.238
  Step 2 (UCLA):        Delta R^2 = 0.0093, p = 0.210 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0002, p = 0.852 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 19.9105, SE = 15.8250, t = 1.26, p = 0.208

UCLA x Gender Interaction (Model 3):
  beta = 4.4876, SE = 23.9797, p = 0.852

Gender-Stratified UCLA Effects:
  Female (n=115): beta = 11.9599, p = 0.540
  Male (n=78):   beta = 31.4852, p = 0.249

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.470
  Shapiro-Wilk p: 0.077


Outcome: PRP Ex-Gaussian mu (SOA 1200, correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0319, p = 0.104
  Step 2 (UCLA):        Delta R^2 = 0.0014, p = 0.603 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0054, p = 0.390 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 6.6871, SE = 12.8258, t = 0.52, p = 0.602

UCLA x Gender Interaction (Model 3):
  beta = 19.8853, SE = 23.0729, p = 0.389

Gender-Stratified UCLA Effects:
  Female (n=114): beta = 4.4252, p = 0.794
  Male (n=79):   beta = 2.4079, p = 0.907

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.429
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 1200, correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0368, p = 0.069
  Step 2 (UCLA):        Delta R^2 = 0.0043, p = 0.344 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0027, p = 0.462 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 5.4369, SE = 5.7298, t = 0.95, p = 0.343

UCLA x Gender Interaction (Model 3):
  beta = 6.4897, SE = 8.7960, p = 0.461

Gender-Stratified UCLA Effects:
  Female (n=114): beta = 0.7811, p = 0.917
  Male (n=79):   beta = 10.7323, p = 0.240

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.800
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 1200, correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0224, p = 0.227
  Step 2 (UCLA):        Delta R^2 = 0.0008, p = 0.691 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0005, p = 0.766 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -5.2068, SE = 13.0881, t = -0.40, p = 0.691

UCLA x Gender Interaction (Model 3):
  beta = 6.2310, SE = 20.9126, p = 0.766

Gender-Stratified UCLA Effects:
  Female (n=114): beta = -3.3003, p = 0.850
  Male (n=79):   beta = -11.5578, p = 0.580

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.874
  Shapiro-Wilk p: < 0.001


Outcome: PRP Delta Plot Slope (Bottleneck, correct) (N = 192)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0080, p = 0.681
  Step 2 (UCLA):        Delta R^2 = 0.0096, p = 0.151 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.899 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 32.5669, SE = 22.5610, t = 1.44, p = 0.149

UCLA x Gender Interaction (Model 3):
  beta = -4.1843, SE = 32.8692, p = 0.899

Gender-Stratified UCLA Effects:
  Female (n=113): beta = 34.2200, p = 0.232
  Male (n=79):   beta = 29.3206, p = 0.469

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.604
  Shapiro-Wilk p: 0.202


Outcome: PRP Vincentile Bottleneck p10 (correct) (N = 192)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0066, p = 0.711
  Step 2 (UCLA):        Delta R^2 = 0.0006, p = 0.741 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0053, p = 0.322 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 4.9386, SE = 14.9411, t = 0.33, p = 0.741

UCLA x Gender Interaction (Model 3):
  beta = 21.5420, SE = 21.7024, p = 0.321

Gender-Stratified UCLA Effects:
  Female (n=113): beta = 1.7756, p = 0.919
  Male (n=79):   beta = 1.7251, p = 0.949

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.518
  Shapiro-Wilk p: 0.087


Outcome: PRP Vincentile Bottleneck p30 (correct) (N = 192)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0111, p = 0.501
  Step 2 (UCLA):        Delta R^2 = 0.0018, p = 0.589 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0181, p = 0.094 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 9.5321, SE = 17.6129, t = 0.54, p = 0.588

UCLA x Gender Interaction (Model 3):
  beta = 45.3543, SE = 26.9201, p = 0.092

Gender-Stratified UCLA Effects:
  Female (n=113): beta = 2.5989, p = 0.900
  Male (n=79):   beta = 2.3929, p = 0.935

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.385
  Shapiro-Wilk p: 0.003


Outcome: PRP Vincentile Bottleneck p50 (correct) (N = 192)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0129, p = 0.438
  Step 2 (UCLA):        Delta R^2 = 0.0087, p = 0.198 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0125, p = 0.189 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 22.9651, SE = 17.7590, t = 1.29, p = 0.196

UCLA x Gender Interaction (Model 3):
  beta = 41.2892, SE = 31.3079, p = 0.187

Gender-Stratified UCLA Effects:
  Female (n=113): beta = 19.4877, p = 0.374
  Male (n=79):   beta = 6.1160, p = 0.836

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.859
  Shapiro-Wilk p: 0.004


Outcome: PRP Vincentile Bottleneck p70 (correct) (N = 192)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0051, p = 0.799
  Step 2 (UCLA):        Delta R^2 = 0.0252, p = 0.026 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0174, p = 0.082 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 40.6859, SE = 18.0758, t = 2.25, p = 0.024

UCLA x Gender Interaction (Model 3):
  beta = 50.7599, SE = 29.0342, p = 0.080

Gender-Stratified UCLA Effects:
  Female (n=113): beta = 31.9853, p = 0.146
  Male (n=79):   beta = 30.3034, p = 0.286

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.628
  Shapiro-Wilk p: 0.202


Outcome: PRP Vincentile Bottleneck p90 (correct) (N = 192)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0053, p = 0.798
  Step 2 (UCLA):        Delta R^2 = 0.0121, p = 0.111 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0011, p = 0.610 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 37.5055, SE = 23.3882, t = 1.60, p = 0.109

UCLA x Gender Interaction (Model 3):
  beta = 17.3577, SE = 33.9914, p = 0.610

Gender-Stratified UCLA Effects:
  Female (n=113): beta = 35.9957, p = 0.236
  Male (n=79):   beta = 31.0457, p = 0.417

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.689
  Shapiro-Wilk p: 0.643


Outcome: PRP Shape Linear Slope (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0021, p = 0.928
  Step 2 (UCLA):        Delta R^2 = 0.0080, p = 0.197 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0126, p = 0.131 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0170, SE = 0.0131, t = -1.30, p = 0.195

UCLA x Gender Interaction (Model 3):
  beta = -0.0317, SE = 0.0209, p = 0.129

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0130, p = 0.438
  Male (n=79):   beta = -0.0127, p = 0.545

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.770
  Shapiro-Wilk p: 0.204


Outcome: PRP Shape Linear Intercept (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0167, p = 0.301
  Step 2 (UCLA):        Delta R^2 = 0.0016, p = 0.578 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0137, p = 0.148 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 15.1879, SE = 27.2901, t = 0.56, p = 0.578

UCLA x Gender Interaction (Model 3):
  beta = 65.2768, SE = 44.9406, p = 0.146

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 11.2903, p = 0.738
  Male (n=79):   beta = -0.4919, p = 0.992

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.799
  Shapiro-Wilk p: 0.017


Outcome: PRP Shape Linear R-squared (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0065, p = 0.716
  Step 2 (UCLA):        Delta R^2 = 0.0003, p = 0.819 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0002, p = 0.853 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0023, SE = 0.0099, t = 0.23, p = 0.819

UCLA x Gender Interaction (Model 3):
  beta = 0.0027, SE = 0.0148, p = 0.853

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0077, p = 0.423
  Male (n=79):   beta = -0.0096, p = 0.667

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.781
  Shapiro-Wilk p: < 0.001


Outcome: PRP Shape Exp Amplitude (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0066, p = 0.698
  Step 2 (UCLA):        Delta R^2 = 0.0010, p = 0.685 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0123, p = 0.131 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 16.1818, SE = 39.8650, t = 0.41, p = 0.685

UCLA x Gender Interaction (Model 3):
  beta = 86.4089, SE = 56.9761, p = 0.129

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -8.3147, p = 0.855
  Male (n=79):   beta = 31.9593, p = 0.659

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.384
  Shapiro-Wilk p: < 0.001


Outcome: PRP Shape Exp Decay Rate (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0099, p = 0.564
  Step 2 (UCLA):        Delta R^2 = 0.0005, p = 0.784 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0008, p = 0.736 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0000, SE = 0.0001, t = 0.27, p = 0.784

UCLA x Gender Interaction (Model 3):
  beta = 0.0001, SE = 0.0002, p = 0.736

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -0.0000, p = 0.755
  Male (n=79):   beta = 0.0002, p = 0.443

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.911
  Shapiro-Wilk p: < 0.001


Outcome: PRP Shape Exp Asymptote (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0292, p = 0.113
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.884 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0002, p = 0.869 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 4.2031, SE = 28.8278, t = 0.15, p = 0.884

UCLA x Gender Interaction (Model 3):
  beta = -8.2754, SE = 49.9841, p = 0.869

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 17.6501, p = 0.604
  Male (n=79):   beta = -16.3742, p = 0.768

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.329
  Shapiro-Wilk p: < 0.001


Outcome: PRP Shape Exp R-squared (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0017, p = 0.954
  Step 2 (UCLA):        Delta R^2 = 0.0080, p = 0.216 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0032, p = 0.455 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0090, SE = 0.0073, t = 1.24, p = 0.215

UCLA x Gender Interaction (Model 3):
  beta = 0.0086, SE = 0.0115, p = 0.454

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0091, p = 0.140
  Male (n=79):   beta = 0.0066, p = 0.690

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.533
  Shapiro-Wilk p: < 0.001


Outcome: PRP Shape Recovery Half-life (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0175, p = 0.308
  Step 2 (UCLA):        Delta R^2 = 0.0043, p = 0.387 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0024, p = 0.547 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -42.3401, SE = 48.8491, t = -0.87, p = 0.386

UCLA x Gender Interaction (Model 3):
  beta = 47.1760, SE = 78.1346, p = 0.546

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -61.7198, p = 0.319
  Male (n=79):   beta = -20.3576, p = 0.821

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.641
  Shapiro-Wilk p: < 0.001


Outcome: PRP Shape Bottleneck (Short-Long) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0027, p = 0.903
  Step 2 (UCLA):        Delta R^2 = 0.0093, p = 0.185 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0160, p = 0.089 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 21.3096, SE = 16.0055, t = 1.33, p = 0.183

UCLA x Gender Interaction (Model 3):
  beta = 41.6219, SE = 24.3223, p = 0.087

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 17.2643, p = 0.386
  Male (n=79):   beta = 14.6559, p = 0.572

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.769
  Shapiro-Wilk p: 0.172


Outcome: PRP Shape Exp Better Fit (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0128, p = 0.470
  Step 2 (UCLA):        Delta R^2 = 0.0002, p = 0.842 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0023, p = 0.528 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0076, SE = 0.0381, t = -0.20, p = 0.842

UCLA x Gender Interaction (Model 3):
  beta = -0.0358, SE = 0.0566, p = 0.527

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0267, p = 0.506
  Male (n=79):   beta = -0.0666, p = 0.396

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.752
  Shapiro-Wilk p: < 0.001


Outcome: PRP Shape SOA Count (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = nan, p = 1.000
  Step 2 (UCLA):        Delta R^2 = nan, p = 0.153 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = nan, p = 0.811 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0000, SE = 0.0000, t = -1.43, p = 0.152

UCLA x Gender Interaction (Model 3):
  beta = -0.0000, SE = 0.0000, p = 0.810

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 0.0000, p = 0.236
  Male (n=79):   beta = -0.0000, p = 0.039

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: < 0.001
  Shapiro-Wilk p: < 0.001

======================================================================
Note. HC3 robust standard errors used for all tests.
======================================================================